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ABSTRACT 
 
Background: In the United States, 26% of deaths are attributable to cardiometabolic 
diseases. Cardiometabolic risk in adolescence tracks over time and can presage 
cardiometabolic health during adulthood. Area-level determinants of cardiometabolic risk 
among adolescents are underexamined.  This study contributes evidence regarding the 
association between area-level poverty and cardiometabolic risk among U.S. adolescents. 
Methods: 1999-2012 National Health and Nutrition Examination Survey data was linked 
via census tract with 2000 Census data and 2005-2009 and 2009-2013 American 
Community Survey data. The sample included 10,415 adolescents, aged 12-19 years. 
Area-level poverty was parameterized by percent population living in poverty, grouped 
into quartiles for analysis. Cardiometabolic risk was parameterized by summing z-scores 
of systolic and diastolic blood pressure, glycosylated hemoglobin, waist circumference, 
HDL cholesterol, and total cholesterol. Hierarchical linear models were used to examine 
Dissertation Title: AREA-LEVEL POVERTY AND 
CARDIOMETABOLIC RISK AMONG 
UNITED STATES ADOLESCENTS: A 
HIERARCHICAL ANALYSIS OF 
PATHWAYS TO DISEASE 
  
 Andrew D. Williams, Doctor of Philosophy, 
2017 
  
Dissertation directed by: Associate Professor Edmond Shenassa 
Maternal and Child Health Program, Department 
of Family Science 
 
the relationship between area-level poverty and cardiometabolic risk. Cotinine levels and 
physical activity were assessed as mediators. Post-hoc analysis explored associations 
between area-level poverty and family poverty-to-income ratio. Analyses were conducted 
for the overall sample and by race/ethnicity. 
Results: For the overall sample, compared to the first quartile of area-level poverty, 
residence in second (.218, 95% CI: .012, .424), third (.438, 95% CI: .213, .665), and 
fourth (.451, 95% CI: .204, .698) quartiles of area-level poverty was associated with 
increased cardiometabolic risk. Area-level poverty was associated with cardiometabolic 
risk among non-Hispanic Whites and Mexican Americans, but not among non-Hispanic 
Blacks. No evidence of mediation was observed. In post-hoc analysis, overall mean 
family Poverty-income-ratio declined from 3.34 in quartile 1 to 1.42 in quartile 4 (p< 
.001), however, this differed by race/ethnicity.   
Discussion: Residence in the highest area-level poverty quartiles was associated with 
increased cardiometabolic risk. Race/ethnicity specific analyses are consistent with 
literature on the Hispanic Paradox, and exposure to adversity among non-Hispanic 
blacks. Evidence suggests specific biomarker choice results in different cardiometabolic 
profiles within the same racial/ethnic group. Post-hoc analyses suggest the effect of area-
level poverty on family PIR is greatest among non-Hispanic whites. Efforts to improve 
cardiometabolic health and reduce racial/ethnic disparities in cardiometabolic diseases 
should include targeted community-level investments aimed to improve the social 
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Chapter I. Overview 
The primary aim of this study was to examine the association between exposure 
to area-level stress during adolescence and cardiometabolic risk during adolescence, 
independently of individual-level determinants of these biomarkers.  The secondary aim 
of this study was to examine whether lifestyle behaviors mediate the relationship between 
area-level stress and cardiometabolic risk, and whether these lifestyle behaviors partially 
explain racial/ethnic disparities in cardiometabolic risk of adolescents.  
In the United States, 26% of all deaths are attributable to cardiometabolic diseases 
such as cardiovascular disease and diabetes.1 Consequently,  the Office of Disease 
Prevention and Health Promotion has identified prevention of mortality from 
cardiometabolic diseases as a national public health priority.2  Prevention of 
cardiometabolic disorders is predicated on identifying its earliest precursors. While 
evidence is accumulating that precursors to cardiometabolic disorders manifest as early 
as adolescence,3–9 the majority of research on cardiometabolic disorders has been 
conducted among adult populations.10–14 Additionally, the American Academy of 
Pediatrics15 and the American Heart Association16 have identified adolescence as a key 
period for cardiovascular disease prevention efforts. 
Cardiometabolic functions, such as blood pressure17–19 and glucose 
metabolism,20,21 track over time. Accordingly, cardiometabolic functions during 
adolescence can presage cardiometabolic health during adulthood. Thus, although 
approximately 99% of adolescents do not meet diagnostic criteria for any 
cardiometabolic diseases,22 adolescents with cardiometabolic function deviating 
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significantly from population-level norms are considered to be at elevated risk of 
developing cardiometabolic disease as adults.6,8,9  For example, among a population-
based sample (n=814) of Ohio youth, high cardiometabolic risk at mean age 13 was 
associated with elevated risk (OR: 11.5, 95% CI: 2.1, 63.7) of developing type-2 diabetes 
during adulthood (mean age 38 years).8 Similarly, among a population-based sample 
(n=1,453) of Finnish youth, high cardiometabolic risk at mean age 13 year was associated 
with elevated risk of type-2 diabetes (RR: 2.54 95% CI 1.25-5.17) during adulthood 
(mean age 23).23 Among this cohort, high cardiometabolic risk during adolescence also 
predicted elevated risk for cardiovascular disease during adulthood (RR: 1.76 95% CI 
1.26-2.43).23 Similarly, among a sample from Louisiana (N=486), high cardiometabolic 
risk during ages 4-17 predicted elevated risk of cardiovascular disease at ages 25-37 
years (OR: 1.42, 95% CI:1.14-1.78).9 Given this evidence, an improved understanding of 
determinants of cardiometabolic risk during adolescence may provide opportunities to 
reduce risk of disease over the life-course. 
Additionally, racial disparities in deaths attributable to cardiometabolic diseases 
have long been recognized.24 Among adolescents in the U.S., non-Hispanic Black 
adolescents have the lowest prevalence of high cardiometabolic risk compared to non-
Hispanic Whites and Hispanics.  This observed disparity is temporally consistent. Non-
Hispanic Black adolescents have the lowest prevalence of high cardiometabolic risk 
(range: 1.6% – 6.4%), followed by non-Hispanic Whites (range: 2.2% – 14.7%), and 
closely followed, typically within 1%, by Hispanic adolescents (range: 2.6% – 
17.5%).3,4,25–30  Furthermore, other evidence points to racial/ethnic differences in health 
behaviors, such as smoking31 and physical activity,32  which have been identified as 
3 
 
predictors of cardiometabolic risk.28,29 No study to date has explored whether racial 
differences in lifestyle behaviors explain racial disparities in cardiometabolic risk among 
U.S. adolescents. 
Individuals’ residential area is another under-examined determinant of disparities 
in cardiometabolic risk among US adolescents.  Health is shaped, in part, by social and 
economic conditions within individuals’ residential area.33,34   Although an inverse 
association between area-level socioeconomic status (SES) and cardiometabolic health 
among adults is well established,14 research on this association among adolescents is 
limited to studies of adiposity and blood pressure.14,35–38 With 2 exceptions,39,40 studies 
conducted in the previous decade consistently observe an association between exposure 
to low-SES areas and elevated risk of adiposity during adolescence.41–56  These studies 
have been conducted among large population-based samples (range: 775-73,079) from 
various countries. 41–56  Of the 16 studies observing an association, 10 conducted 
hierarchical analysis.41–43,46,48,52–56 Six longitudinal studies suggest individuals residing in 
low-SES areas are heavier at baseline, and gain more weight during adolescence than 
individuals in high-SES areas.43,50–53,55  
In contrast, only four studies (sample range: 24 – 325) have examined the link 
between area-level SES and blood pressure among adolescents,35–38 and one found an 
association.35 None of these four studies conducted appropriate hierarchical analyses,35–38 
and two included only individuals with a family history of cardiometabolic disease.36,38  
To date, the potential association between area-level SES and other 
cardiometabolic factors, including glucose metabolism and lipid levels13,57–60 among 
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adolescents remain unexamined. Furthermore, cardiometabolic functions cluster6,13,58,61 
and are often considered together in an index representing an individual’s 
cardiometabolic risk.6,13,58,61 To date, no studies have examined the association between 
area-level poverty and a continuous index of cardiometabolic risk among adolescents. 
Additionally, evidence among adults suggests area-level SES contributes to racial 
disparities in cardiometabolic health,62,63 yet similar studies among adolescents are sparse 
and have focused solely on adiposity.  Four studies of population based samples (range: 
17,100 – 20,745) of U.S. children and adolescents using hierarchical methods suggest 
area-level SES contributes to racial disparities in adiposity.48,54,64,65  For example, among 
US adolescents, accounting for area-level SES resulted in 18% reduction in odds of 
adiposity for non-Hispanic black girls compared to non-Hispanic white girls.65 Among 
another sample of US children and adolescents, the racial-ethnic disparity in the odds of 
adiposity was explained away by addition of area-level SES.54   To date, no study has 
examined the link between area-level SES and racial disparities in cardiometabolic risk 
using a cardiometabolic risk index among adolescents.  
This study describes associations between area-level poverty (as an indicator of 
area-level SES) and cardiometabolic risk among adolescents. We also examine 
racial/ethnic disparities in this association. Furthermore, mediation by lifestyle behaviors 
is also assessed. We fit hierarchical models, for the full sample and by race, to determine 
the association between area-level poverty and cardiometabolic risk among a nationally 
representative sample of adolescents free of diagnosed cardiometabolic disease. We 
hypothesized that residing in areas with high poverty would result in an increased 
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cardiometabolic risk score, and exposure to tobacco smoke and physical activity would 
partially explain observed differences by race. 
To better understand the potential link between area-level poverty and 
cardiometabolic risk, and to examine the role of lifestyle behaviors, the following specific 
aims were proposed: 
1. Determine the relationship between area-level poverty and cardiometabolic risk, 
independent of individual- and area-level covariates. 
2. Determine if the relationship between area-level poverty and cardiometabolic risk 
differs by race/ethnicity. 
3. Determine if exposure to tobacco smoke, as a mediator between area-level 
poverty and cardiometabolic risk, partially explains racial/ethnic disparities in 
cardiometabolic risk. 
4. Determine if physical activity, as a mediator between area-level poverty and 









Chapter II. Area-level Determinants of Health 
Both individual- and area-level determinants of health are important in 
understanding the panoply of influences that determine health.  Area-level determinants 
of health include physical, social, and environmental exposures. A key area-level 
determinant of health is area-level socioeconomic status (SES). Area-level SES is related 
to both indirect and direct determinants of health, such as access to resources (e.g. food 
stores, health care)54 and exposure to environmental toxins.66 How area-level SES is 
assessed is important and is a key aspect in understanding how area-level SES impacts 
health. 
Racial/ethnic composition at the area-level has been utilized as a measure of 
SES,35 yet may be an inappropriate measure of SES, as areas with high racial/ethnic 
minority populations can have high SES, just as areas with high racial/ethnic majority 
populations can have low SES.67,68  Moreover, racial/ethnic composition is associated 
with health, even after controlling for area-level SES, suggesting that while these two 
constructs are related, they are separate area-level exposures.69–71 It stands to reason that 
a more direct method of assessing area-level socioeconomic status can be more useful. 
Economic indices are useful indicators of both area-level SES and are considered 
area-level stressors.  They are easily interpretable, consistently measured over time, and 
relate well to multiple other measures of area-level SES such as housing quality, crowded 
living spaces, and the built environment.72–75 Concentration of poverty, the percent of 
individuals living below the federal poverty line, is a common measure of area-level 
SES.54,64,72–74  Other measures including educational attainment, median household 
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income, percent unemployment, and median home value are indicative of access to 
resources (e.g. healthy food, insurance coverage, safe housing) and other area-level 
stressors (e.g. crime and violence).  
Singular indices of area-level SES allow for greater ease in interpretation, yet may 
not fully depict area-level stressors. Multivariate indices are conceptualized to allow for a 
more robust complete assessment of the area-level stress, yet due to their complexity, it 
may be difficult to determine which economic factors are driving an association. 
Multivariate indices that have transformed and averaged multiple indicators of area-level 
SES (e.g. educational attainment, employment, concentration of poverty, percentage of 
female-headed households) have been linked with health outcomes.54,64 Yet, using 
concentration of poverty at the census-tract level as a singular indicator is easily 
interpretable, and has been shown to produce similar results as multivariate indices.54,72–74 
Among adolescents, the potential association between area-level exposures and 
biomarkers that predict future development of disease have rarely been examined. As 
exposure to area-level SES during adolescence has been linked with adult health 
outcomes,76,77 examining the potential links between area-level SES and biomarkers of 
cardiometabolic risk which track over time (such as blood pressure and glycosylated 
hemoglobin) among adolescents may allow for a better understanding of area-level 






Chapter III. Blood Pressure among Juveniles 
As this study attempts to better understand the pathways to disease, blood 
Pressure (BP) is an appropriate biomarker to examine as it is a good indicator of health, 
and can be tracked across the lifespan. Literature reviewed in this chapter incorporates 
both children (less than 12 years of age) and adolescents, (between 12 and 19 years of 
age) as the extant literature as largely considered these distinct age group together. BP 
during adulthood is associated with risk of cardiovascular disease, stroke, premature 
death, and other health problems in adulthood.78–82 Longitudinal studies provide evidence 
that BP tracks over time among juveniles. BP in early childhood is independently 
predictive of BP in adolescence.83 BP has also been tracked during adolescence, as BP at 
age 13 correlates with BP at age 17.84 Most relevant to the proposed study, is the 
consistent observation that adolescents with high BP levels are likely to have high BP 
levels in adulthood.17–19 
Measurement of blood pressure 
 There are two components to blood pressure (BP): systolic blood pressure (SBP) 
is the blood pressure during a heartbeat, and diastolic blood pressure (DBP) is the blood 
pressure between heart beats.85,86 Hypertension is diagnosed when SBP or DBP are at or 
above the 95th percentile based on age, gender, and height.87 Another measure is blood 
pressure reactivity (i.e., rise and fall of BP) in response to a stressor.88–91 This review 
focused on BP levels and hypertension, as these two indicators are considered to be risk 
factors for development of future disease.17–19  
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Additionally, SBP and DBP are highly correlated and have many of the same 
determinants, these shared determinants were identified as a determinant of overall 
BP.85,86 Determinants of only SBP or only DBP were identified as such. However, SBP is 
considered a stronger predictor of disease,85,86 and determinants unique to SBP (i.e. 
sodium intake18,92) have been identified.  
Distribution of BP among juveniles 
Age-gender-height specific BP charts based on 1999-2000 National Health and 
Nutrition Examination Survey (NHANES) data can be used to provide normative 
references for juvenile BP.87 For example, according to this chart the 50th percentile for 
systolic blood pressure (SBP) for a 5 year old female at the 50th percentile for height is 
93, while the 50th percentile for SBP for a similar male is 95.87 The gender difference 
becomes more apparent in adolescence, as the 50th percentile for SBP for a 17 year old 
female at the 50th percentile for height is 111, while the 50th percentile for SBP for a 
similar male is 118.87  
From NHANES 1999-2012, for youth aged 8-12 years, boys had mean SBP of 
102.96 mean DBP of 52.97, and girls had mean SBP of 102.09, and mean DBP of 
54.39.93 For youth aged 13-17 years, boys had mean SBP of 111.99, and mean DBP of 
58.74, and girls had mean SBP of 106.48, and mean DBP of 61.57. 93 Also from 
NHANES 1999-2012, the prevalence of prehypertension and hypertension among youth 
aged 8-17 years has remained near 10 percent for much of the previous decade.7 
Demographic correlates of BP in juveniles 
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Blood pressure co-varies with age, gender, and height.  Among juveniles age has 
an independent and positive association with blood pressure (BP).18,94–96 This age-related 
increase in BP is normative, and is not considered a risk factor among this population.  
 Furthermore, male juveniles have elevated BP levels compared to females, with 
large increases in SBP observed in males during adolescence, yet not in females.18,84,94 
Physiologic changes in adolescence likely drive gender-based differences in BP. For 
example, males have larger skeletal and muscle growth, and larger gains in red blood cell 
mass than females, and this contributes to higher increases in BP levels seen in males 
during adolescence.18,94,97 While hormonal pathways are not yet well specified, 
differences in estrogen receptors between genders may be partially responsible for 
elevated levels of BP in males.84  
Finally, BP also co-varies with height.18,83,87,94,95,98 Therefore, age, gender, and 
height must be taken into account when determining normal levels of BP in juveniles. 
Determinants of BP among juveniles 
Although there is a wealth of knowledge of determinants of blood pressure (BP) 
among adults, research on juveniles is not as prevalent. Twenty-six studies have 
examined individual- and area-level determinants of adolescent SBP and DBP,  and 
hypertension.17,18,35–38,75,83,84,92,94–96,98–110 Studies measuring BP at 5 years of age and 
above are of particular interest to this review in order to examine BP levels tracking over 
time in childhood and adolescence. In the review below children below age 12 and 
adolescents aged 12-19 are referred to as juveniles.111,112 
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Prenatal and neonatal factors play an important role in juvenile BP. Maternal age 
and height, pre-pregnancy BMI, number of previous pregnancies, and smoking 
throughout pregnancy, are all independently and positively associated with juvenile 
SBP.109  Birthweight is also inversely related with BP among adolescents.83,96 
Additionally, juveniles who were breastfed at least 6 months have lower SBP in 
childhood.109,110   
Family characteristics are also linked with juvenile BP.37,94,96,103,106,107 Juveniles 
from families with a history of hypertension or cardiac arrest are more likely to have high 
BP levels.96,107 This relationship may signal hereditary factors in BP, or it could be 
indicative of the health behaviors of the family or other shared influences such as SES. 
Family SES correlates well with exposure to stress, and various indicators of low family 
SES (i.e. low income and assets, poor parental education, female-headed household, low 
paternal education) are associated with elevated juvenile BP.37,103,106 However, one study 
found that juveniles with low family SES had lower BP levels than others.94 Additionally, 
family SES is also related to access to resources, yet it may be more appropriate to 
measure health behaviors related to certain resources in order to better understand how 
family SES is linked to juvenile BP.37 
Access to healthy food and quality housing are intrinsically tied to family SES, 
and influence health behaviors such as diet and sleep.113–115 Sodium intake is positively 
associated with SBP, and sugar intake is positively associated with overall BP 
levels.18,92,100,109 High sodium intake may further elevate SBP in obese juveniles, as 
sodium may interact with obesity-related health conditions (e.g. metabolic syndrome, 
hyperinsulinemia) leading to elevated SBP.18,92 High sugar intake effects BP levels by 
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increasing production of nitric oxide in the kidneys, leading to elevated BP.100 Inefficient 
sleep is thought to lead to metabolic and endocrine disorder, in turn leading to elevated 
SBP in juveniles.99  
Adolescent Growth and BP 
Measures of body size, other than height, are also independently associated with 
BP levels. While increases in weight, head circumference, waist circumference, and 
waist-to-height ratio are associated with elevated BP, Body Mass Index (BMI) is the most 
widely used measure.18,83,94–96,98,101,102,104,108 The association between BMI and BP 
becomes stronger as BMI increases.94–96 Normative increases in BMI are associated with 
normative increases in BP, yet excessive increases in BMI greatly increase risk for 
prehypertension and hypertension.101 94–96  The relationship between BMI and BP is 
complicated by rate of growth during childhood.  Children with high BMI may grow 
faster than others, leading to higher than average height for their age. 94 This interaction 
between height, BMI, and growth is physiologically complicated, not allowing the true 
relationship between BMI and BP to be clearly distinguished.94 
Rate of growth may play an important role in adolescent BP levels, as 
adolescence is the only developmental period after infancy in which the rate of growth 
accelerates, and great physiological changes occur to prepare the body for adulthood.97,116 
A study of  rate of growth from infancy to age 5 observed an inverse relationship  
between rate of growth during early childhood and adolescent BP; whereas, rate of 
growth from age 5 to 15 was independent of adolescent BP.83 However, rate of growth in 
adolescence is age and gender dependent. For instance, until approximately age 10, males 
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and females have similar height, yet during early adolescence (approximately 10-12 years 
of age), females make larger gains in height than males.116 Later in adolescence 
(approximately 12-13 years of age), males catch up to and overtake females in terms of 
height and rate of growth. 116 Measuring rate of growth over a 10 year period 
encompassing both childhood and early adolescence may have obscured the true 
relationship between rate of growth and BP in juveniles. Due to accelerated rate of 
growth and physiologic changes associated with adolescence, children and adolescents 
should not be considered a single group when assessing BP levels and other health 
outcomes.87,97 
Many of the reviewed studies are either cross-sectional studies unable to measure 
rate of growth,17,18,35–38,75,92,94–96,98–109 or longitudinal studies that did not measure growth 
over time.84,110  As age is related to growth in children and adolescents, these studies 
account for age in analysis. Accounting for age may partially account for growth, yet the 
true relationship between rate of growth and BP cannot be observed in cross-sectional 
studies. 
Area-level studies 
To date five studies have considered the association between area-level 
determinants (i.e., concentration of poverty, proportion of residents with less than high 
school level of education, multivariate index of SES, built environment) of juvenile 
BP.35–38,75  The only study to observe a relationship between area-level SES and BP 
examined concentration of poverty at the census tract level.35 In contrast, the studies with 
null findings used indicators of area-level SES at the block group level.36–38 These 
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findings, in the context of the discussion of area-level units of analysis in chapter 6, 
suggest that constructs may operate differently depending on unit of analysis, and this can 
result in different effects.  
Additionally, the study to observe a relationship fit hierarchical models to nest 
individuals within schools.35 In contrast, studies with null findings estimated bivariate 
correlations 37,38  and another conducted a multivariate analysis of covariance but without 
considering the two levels of analysis. Given that in all these studies individuals are 
nested within various contexts, such as neighborhoods and schools, hierarchical models 
are most appropriate.36–38 (See chapter 6 for a discussion of hierarchical models).  
Furthermore, of the studies with null findings, one study sampled participants 
from a single school district, 37 while others sampled from a small number of schools.36,38 
Additionally, two studies included only individuals with a family history of 
cardiovascular disease in the sample.36,38 The studies with null findings were likely 
limited in the variability of the outcome variable, as well as the predictor variables at both 
the individual and area levels. 
The study to observe an association between area-level SES and BP sampled 212 
students from two schools.35 The sample was diverse in regards to racial/ethnic 
background and socioeconomic status, yet the small sample resulted in all tract-level 
factors to be treated as individual-level factors, thus not allowing for true hierarchical 
analysis of the relationship between area-level SES and BP.35 A large, nationally 
representative sample allows for better generalizability, as well as the potential for a 




Exposure to Stress and Blood Pressure 
BP is responsive to stress. In the face of acute stressors, BP rises and returns to 
basal levels once the stressor is mitigated.82,117–119 As discussed in chapter 5, the HPA 
axis releases hormones such as epinephrine when faced with a stressor.119 These 
hormones increase heart rate and narrow blood vessels, thus increasing blood pressure.  
Evidence has also linked area-level stressors with elevated basal levels of BP, yet 
research examining this relationship among juveniles is scarce.35 Exposure to place-based 
stress may lead to continual HPA activity and resultant physiologic consequences, as 













Chapter IV. Glycosylated Hemoglobin among Juveniles 
This study focuses on the relationship between exposure to placed-based stressors 
and stress-related biomarkers to better understand how physiologic reaction to stressors 
may provide a pathway to disease. Glycosylated hemoglobin (HbA1c) is an important 
biomarker of exposure to chronic stress,120–122  and it is also a marker of prediabetes123–127 
and cardiovascular disease.128–131 Much of the research on the relationship between 
chronic stress and HbA1c has occurred among adults, yet examining this potential 
relationship among juveniles may provide a better understanding of the link between 
chronic stress and future disease. Literature reviewed in this chapter incorporates both 
children (less than 12 years of age) and adolescents, (between 12 and 19 years of age) as 
much of the relevant research has focused on diabetic individuals under the age of 19.  
Glycosylated hemoglobin 
HbA1c represents the average blood glucose level over approximately three 
months, with high HbA1c levels suggesting poor blood glucose regulation.123,124 While 
traditionally used to determine average glucose levels among diabetics, HbA1c levels 
have recently been recommended for use in screening for prediabetes among adults.123–127 
Prediabetes is a condition in which blood glucose levels are higher than normal, yet 
below diagnostic criteria for diabetes; prediabetes is often a precursor to Type 2 
diabetes.132 Cross-sectional studies have identified a link between HbA1c and 
cardiovascular disease among adults, with evidence suggesting the severity of 
cardiovascular disease increases with elevated HbA1c.128,131 In a longitudinal study 
among adults examining how well various biomarkers of glucose regulation (HbA1c, 
fasting glucose, 2 hour post prandial glucose) predict onset of cardiovascular disease, 
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HbA1c was the most accurate predictor of cardiovascular disease and mortality over a 10 
year period.129 Another longitudinal study found that adults without diabetes with 
elevated HbA1c (≥6.2%) over a 5 year period were more likely to have cardiovascular 
disease compared to individuals with lower levels of HbA1c (<6.2%).130  
 Among diabetic juveniles, HbA1c is a key biomarker of glucose regulation, and 
much of the existing research on HbA1c among juveniles has focused on this 
population.20,123,133–147 Research examining HbA1c among juveniles without diabetes has 
largely focused on high-risk (e.g. overweight or obese) populations, as weight and Body 
Mass Index are key risk factors for diabetes and heart disease.148,149 Among obese 
juveniles, initial studies suggested HbA1c may not be an appropriate screen for 
prediabetes or diabetes,123,148,149 yet more recent studies suggest measuring HbA1c levels 
is a valid screen for prediabetes and diabetes.150,151 While all studies found the same 
association, initially observers123,148,149 were hesitant to recommend HbA1c as a screen 
for prediabetes and diabetes due to lack of research, while the more recent studies150,151 
reflect a better understanding of HbA1c as a screening measure. However, no clinically 
relevant cut point for HbA1c levels for use in screens has been established. 123,148–151  As 
utility of HbA1c as a biomarker of disease among high-risk and non-high-risk 
populations increases,152 this study focuses on the general population in order to better 
understand the effect area-level exposures have on HbA1c. Additionally, HbA1c tracks 
over time among diabetic20 and non-diabetic children,21 underlining the importance of 





Glucose Regulation and Chronic Stress 
Among adults, exposure to chronic stress has been linked with elevated levels of 
HbA1c among both diabetics121 and non-diabetics.120,122  Insulin is a key factor in the 
pathway linking exposure to chronic stress with elevated levels of HbA1c.120,121 
Insulin is a hormone produced by the pancreas that plays a major rule in blood 
glucose regulation.153 When blood glucose levels are high, insulin is released and triggers 
cells to store glucose for future use and inhibits additional glucose secretion, thus 
lowering blood glucose levels.153 If insulin production is inhibited, this can lead to 
chronically high blood glucose levels and severe health consequences, such as diabetes 
and cardiovascular disease.125–129 Exposure to chronic stress has been linked with 
inhibited insulin production and poor glucose regulation.120,121 
As discussed in chapter 5, chronic exposure to stress can lead to a continual 
activation of the HPA axis and continual release of adaptation hormones such as cortisol. 
Continual release of cortisol, can lead to both an increased production of glucose and 
inhibited production of insulin.154–157 Exposure to chronic stress is also linked with 
elevated levels of c-reactive protein, a marker of inflammation,158 in turn, inflammation 
has been linked with insulin resistance.120,159 In sum, chronic stress leads to elevated 
levels of HbA1c as glucose production is increased, insulin levels are reduced, and 
inflamed cells are less likely to respond to insulin.120,154–159  
Distribution of HbA1c among Juveniles 
Among a nationally representative sample of juveniles without diagnosed 
diabetes, the mean HbA1c among individuals aged 5 to 9 years is 4.98% (10th- 95th 
percentile: 4.46-5.47); among individuals aged 10 to 14 years, the mean is 5.03% (10th - 
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95th percentile: 4.53 - 5.57); those aged 15-19 years had a mean of 4.97% (10th - 95th 
percentile: 4.45 - 5.51).152 The heightened HbA1c levels among those aged 10-14 years is 
likely due to normative insulin resistance that occurs in early adolescence.160,161  Among 
juveniles from NHANES 1988-1994 data, the prevalence of elevated HbA1c (≥6 percent) 
was 0.39%.162 
Gender differences in HbA1c levels among juveniles have also been observed 
across age groups in large, nationally representative studies.152,163–165 In studies utilizing 
NHANES 1988-1994 data, males had higher average HbA1c in the overall sample, and 
when stratified by age and race/ethnicity.152,163 In the study of adolescent blood donors, 
boys had higher prevalence of elevated HbA1c overall, and when stratified by 
race/ethnicity. 164 
 
Determinants of HbA1c among juveniles without diabetes 
Studies examining the distribution of HbA1c and prevalence of elevated HbA1c 
among juveniles observed differences by racial/ethnic group. 152,163–165 Studies utilizing 
NHANES 1988-1994 data found that across each age group, non-Hispanic Blacks had the 
highest mean HbA1c, followed by Mexican-Americans, and non-Hispanic Whites, 
respectively. 152,163 In the study of adolescent blood donors, prevalence of elevated 
HbA1c (≥5.7 percent) was highest among non-Hispanic Blacks (32.7 percent), followed 
by Asians (19.7 percent), Hispanics (13.1 percent), and non-Hispanic Whites (8 
percent).164 Studies suggest that race/ethnicity is a key predictor of HbA1c among 
juveniles, with racial/ethnic differences remaining after controlling for other determinants 
such as SES, and body mass index.163 
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Among NHANES (1988-1994), determinants of HbA1c among juveniles without 
diabetes  include juvenile BMI, maternal BMI, and family income to poverty ratio, yet 
these relationships became non-significant in multivariate models once race/ethnicity was 
included.163 Among Dutch children without diabetes, HbA1c was found to be 
independent of ethnicity, BMI, waist circumference, parental diabetes status, and 
maternal BMI.166 A study of Native American juveniles observed a relationship between 
intrauterine exposure to diabetes and HbA1c, yet body fat percentage was not a 
determinant.167 In sum, demographic factors (i.e., age, gender, race) are the only factors 
that have been consistently linked with HbA1c. 
Stress and HbA1c among Juveniles 
Eleven studies have examined the relationship between stress and HbA1c among 
juveniles with diabetes.20,133–142 These studies suggest that individual- and family-level 
stressors, such as negative life events and family socioeconomic status, are linked with 
HbA1c among this population.20,133–142 None of these studies considered area-level 
stressors. 
Two studies have examined the relationship between stress and HbA1c among 
juveniles without diabetes.143,144 A cross-sectional study of 6 year olds examined the 
relationship between family-level stressors and HbA1c, yet neither parent-reported 
negative life events nor family socioeconomic status were associated with HbA1c levels; 
area-level stressors were not considered in this study.143 The sole study examining area-
level stressors and HbA1c was a longitudinal study among 11,100 adolescents.144  Results 
suggest that living in a context with low collective efficacy during adolescence was 
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associated with increased odds of having elevated HbA1c (>5.7 percent) in early 
adulthood.144  
While the literature on stress and HbA1c among juveniles without diabetes is 
sparse, current findings suggest a potential relationship. Findings are consistent with the 
notion that exposure to stress must accumulate in order to negatively impact health. The 
link between stress and HbA1c was not observed among 6 year olds as they have not 
accumulated enough exposure to stress to influence a physiologic outcome.143 As 
exposure to stress accumulates, physiologic consequences are observed, as evidenced in 
the longitudinal study of adolescents.144  
Exposure to chronic stress has been linked with biomarkers of future disease 
among adults, yet this remains understudied among adolescents. As discussed in chapter 
5, the physiologic response to chronic stress may shift the body’s physiologic balance to 











Chapter V. Stress and hypothalamic-pituitary-adrenal activity during adolescence 
Homeostasis refers to the body’s physiologic balance, the optimal ranges that 
physiologic systems operate within under normal conditions.168,169 This homeostatic state 
is maintained by the hypothalamic-pituitary-adrenal (HPA) system through its 
interconnections with multiple biologic systems (i.e., central nervous, immune, 
cardiovascular, inflammatory, and endocrine systems).154,156,170–173  Exposure to stressors 
results in the release of two sets of hormones by the HPA axis: adaptation hormones and 
growth hormones.174 Adaptation hormones provide energy for the fight or flight response 
through increased heart rate, blood flow, respiration, as well as immune and 
inflammatory responses.154,156,170–174 For example, cortisol, a key adaptation hormone, 
breaks down proteins and regulates glucose levels, providing energy for the fight or flight 
response.154–156 After an acute stressor is resolved, growth hormones, such as insulin, 
growth hormone174 and dehydroepiandrosterone (DHEA), allow a return to homeostasis 
by counteracting the arousal effects of adaptation hormones.155,174–176 More specifically, 
as an acute stressor is mitigated, release of growth hormones allow cells to store glucose 
for future use and the body to relax, this is referred to as a “restorative break.”174,177 
A critical distinction between acute and chronic stressors in terms of HPA activity 
is that exposure to chronic stress prevents the onset of restorative breaks.  Chronic 
exposure to stressors results in continued and excessive release of adaptation hormones, 
causing a shift in the adaptation-growth hormone balance in favor of adaptation 
hormones.  This shift reduces the effect of growth hormones, preventing onset of 
restorative breaks.174 Lacking restorative breaks, the HPA continues release of adaption 
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hormones with  physiologic consequences.174 As discussed below, continual HPA activity 
may have severe consequences, especially among adolescents.  
Another possible consequence of repeated exposure to stressors that cease (due in 
part to some action of the individual) is development of a sense of mastery over that 
stressor.  This sense of mastery is physiologically expressed as a less pronounced spike in 
cortisol when faced with the acute stressor, allowing for a quicker onset of restorative 
breaks and return to homeostasis. 174 For example, novice pilots experience elevated 
levels of both cortisol and growth hormone following exposure to experimentally induced 
stressors while expert pilots have increased levels of growth hormone only.174,178 The 
elevated levels of growth hormone in conjunction with low levels of cortisol suggest that 
the expert pilots had learned to manage the stressor; therefore, a quicker onset of a 
restorative break occurs, allowing energy to be available for functions other than stress 
management.  Likewise, in animal studies, repeated exposure to acute stressors early in 
life leads to lower basal cortisol levels and smaller spikes in cortisol in response to 
similar stressors later in life. 174,179–182 In summary, exposure to chronic stressors inhibits 
onset of restorative breaks. Inhibition of restorative breaks may uniquely effect 
adolescents due to a normative period of heightened HPA activity during this 
developmental period.  
HPA activity during Adolescence 
Adolescence is a unique period of HPA activity.  For reasons that are not fully 
understood,183–185 adolescents enter a normative period in which basal levels of both 
adaptation and growth hormones are elevated.183–193 To the extent that exposure to acute 
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stressors of adolescence, such as changing social roles and integration into the larger 
society, is prevalent, adolescence is a time of particularly high HPA activity.183,186,194–197 
Furthermore, during adolescence the HPA axis responds to stressors in an exaggerated 
manner.183,184,186,195–200 For example, compared to adult rats, adolescent rats experience 
larger spikes in HPA hormones in reaction to stressors, and require a longer period to 
return to basal HPA levels following the spike.198–200 In humans, when children and 
adolescents are exposed to a similar stressor, adolescents have a larger spike in cortisol 
than children.183,184,186,201  With age, individuals’ stress response becomes less 
pronounced, with lower spikes in hormonal levels and a quicker return to basal levels 
throughout adulthood.198–200,202  
Consequence of Exposure to Chronic Stress 
 Chronic physiologic reaction to stressors and anticipation of exposure to stress 
may lead physiologic systems (such as the cardiovascular system and the immune 










Chapter VI. Methods 
The purpose of this study was to determine the relationship between area-level 
poverty (a measure of area-level stress) and cardiometabolic risk in adolescents. This 
chapter describes the data sources, variables analyzed in this study, and analysis. 
Individual-level Data 
All individual-level data was drawn from the 1999-2012 waves of the National 
Health and Nutrition Examination Survey (NHANES). NHANES is a continuous, cross-
sectional survey that provides vital and health statistics for the United States population. 
209,210 NHANES began as a series of surveys in the 1960s, and since 1999 has been a 
continuous survey, releasing data every 2 years.209,210 The survey utilizes a population-
based, nationally-representative sample of the non-institutionalized United States 
population.209,210  NHANES uses a 4 stage sampling procedure. 211 Stage 1 identifies and 
selects Primary Sampling Units (PSUs) that typically consist of one county, or groups of 
contiguous counties. Stage 2 divides PSUs into segments equivalent to the size of a city 
block. Stage 3 identifies and selects households within each selected segment, and a 
sample is randomly drawn from the existing households. Stage 4 identifies and selects 
individuals within each household, and randomly selects a participant by age, sex and 
race/ethnicity.211 Certain groups are of particular interest to public health officials and 
researchers, and NHANES is designed to oversample these groups in order to provide 
reliable statistics. 209–213 In the 2007-2012 waves of NHANES, Hispanics, Non-Hispanic 
Blacks, Non-Hispanic Asians, Non-Hispanic Whites at or below 130 percent of the 
poverty level, and Non-Hispanic whites aged 80 years and older were oversampled.212,213 
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This procedure results in a sample of approximately 5,000 people across 15 PSUs per 
year.209,210  NHANES data are collected via a Household Interview, a Mobile 
Examination Center (MEC) visit, and Post-Mobile Examination Center procedures using 
standardized questionnaire interviews, clinical examinations and laboratory 
procedures.209,210,214   
During the Household Interview, a trained interviewer first screens the household 
and residents for participation. The screening process gathers information on age, gender, 
race/ethnicity, and income; this information is used in an algorithm to randomly select 
participating households and participants. For selected households, the relationship 
questionnaire divides all household residents into family units in order to identify the 
number of families residing in a household. Informed consent is obtained for all selected 
participants, who are then interviewed for information related to demographics, 
socioeconomics, dietary and health history. For each family unit within a sampled 
household, a family questionnaire obtains information on education, race/ethnicity, 
family income, occupation and other household characteristics.  
After the Household Interview, selected participants are scheduled for an 
appointment at the Mobile Examination Center (MEC) for laboratory and clinical 
assessment. The MEC set up in a location easily accessible to participants in a selected 
PSU. The MEC is a combination of 4 trailers containing exam rooms and equipment 
needed for data collection. During the MEC visit, trained staff collect data related to 
components such as audiometry, anthropometry, blood pressure, body composition, bone 
density, cardiovascular fitness, oral health, and a physician examination, among others. 
Participants also complete a dietary interview, and a private health interview (covering 
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topics such as current health status, substance use and physical activity) during the MEC 
visit. Biospecimen samples of blood, hair, nasal swab, urine, vaginal swab, and glucose 
tolerance are collected and sent to external laboratories for analysis.214 
A sub-sample of participants are also recruited to participate in Post-MEC Data 
Collection. This data collection includes allergen data, dietary interview, physical activity 
monitoring, health questionnaire, and urine sample. Post-MEC Data Collection is 
completed via phone interview, in-home questionnaire, and mailed return of completed 
tasks (i.e. urine collection and physical activity monitoring) to appropriate laboratories 
for analysis.214  
Sample 
 Individuals were drawn from the 1999-2012 waves of NHANES. Combining 14 
years of NHANES data provides greater statistical reliability, is more representative of 
the United States population, and provides greater geographic variability in the sample. 
This study focuses on a subset of male and female adolescents aged 12 to 19 from 
NHANES. The sample included individuals from all racial/ethnic groups. Individuals 
with a self-reported diagnosis of diabetes that are currently using medication/insulin to 
control their blood glucose levels were not included in the subset as medication/insulin 
use may result in altered HbA1c levels. Individuals with a self-reported diagnosis of 
hypertension that are taking medication to treat hypertension were not included in the 
subset as medication use may result in altered BP levels. Individuals reporting current 
pregnancy were not included in the subset as pregnancy influences cardiometabolic 
biomarker levels.215216  
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The analytic sample was drawn from 13,343 adolescents, ages 12–19 years who 
completed examination in the mobile examination center (MEC).  We excluded 
respondents who reported to be pregnant (n=181), had been told by health professional to 
have hypertension or diabetes and using medication for hypertension or diabetes (n=83).  
Of the remaining 13,079 adolescents, 2,934 were excluded due to missing data on 
cardiometabolic outcome variables, leaving a final analytic sample of 10,415 adolescents 
(79% of sample who completed the mobile examination center component).   
Area-level Data 
 Area-level data were drawn from the 2009-2013 American Community Survey, 
the 2005-2009 American Community Survey, and the 2000 Decennial Census. 3,140 
census tracts were included in analysis. 
Fully implemented in 2005, the American Community Survey (ACS) is a 
continuous survey of demographic, social, and economic indicators (e.g., poverty, 
education, family makeup, and housing). Since 2010, the ACS has replaced the long form 
Decennial Census in order to provide contemporary statistics for the United States 
population. The United States Census Bureau collects and releases data annually. The 
ACS samples approximately 3,500,000 addresses in the United States each year. Data are 
released in 1-year, 3-year, and 5-year estimates, with multiyear estimates combining data 
from the previous 3- or 5-year periods.217 This study used 5-year estimates as they 
include the largest sample size, are considered the most accurate, and provide estimates 
for small geographic units.  
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The 2000 decennial census was a cross-sectional survey that collected 
demographic, social, and economic indicators (e.g., poverty, education, family makeup, 
and housing). As the decennial census collects data from all households in the United 
States, decennial census data accurately describes the United States population in the year 
2000. Decennial census data provides statistics for multiple levels of geography in the 
United States.218 With multiple levels of geography available in Census and ACS data, it 
is important to identify an appropriate geographic unit of analysis with which to depict 
area-level poverty. 
Area-level Units of Analysis 
When examining area-level determinants of health it is important to determine the 
appropriate geographic unit of analysis that allows for observation of the construct of 
interest as well as adequate statistical power to observe an association reliably.   
Area-level units of analysis range from census blocks to nations. Larger 
geographic units include many smaller geographic units that have been shown to be 
relevant to the health of individuals within those units.72 While factors such as income 
inequality measured at national or state levels219–221 have been linked to health outcomes, 
much of the research on area-level determinants of health utilizes smaller geographic 
units, such as census block group, census tract, or ZIP codes. Additionally, some 
constructs are more relevant at smaller geographies (e.g. social cohesion) while others are 
only relevant in larger geographies (e.g. income inequality).222 
Krieger et al examined how heterogeneity of various units relates to consistency 
of observations. Relatively smaller geographic units have more homogenous populations 
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and allow for the most consistent observations.72–74 Census block groups (on average, 
1,000 residents) and census tracts (on average,  4,000 residents) are considered to have 
relatively homogeneous populations, and both block groups and census tracts yielded 
consistent observations between area-level exposures and health outcomes.72–74 In 
contrast, ZIP codes (on average, 30,000 residents) have relatively more heterogeneous 
populations, and inconsistent observations.72–74 Furthermore, similar relationships at the 
block group and tract levels exist.223,224 For many social constructs related to area of 
residence, census tracts are also considered to be the more socially relevant geographic 
unit.225,226 Tract boundaries are derived with input from local communities in attempt to 
capture natural neighborhood boundaries.227 Furthermore, aggregating resident-reported 
data to the tract level can result in socially relevant variables (e.g. collective efficacy) that 
have links to health outcomes.228,229 Additionally, tracts are utilized by federal, state, and 
local entities for resource allocation and to determine eligibility for social programs. 225–
227  Due to these factors, census tracts are considered to best approximate social context 
compared to other small geographic units of analysis. 
Other considerations are statistical power, precision of estimates, and reliability 
that a particular unit of analysis allows. High margins of error occur when population 
among a particular unit is small.223,224 Census tracts, on average, have a larger population 
than block groups.72–74  Therefore, while similar relationships at the block group and tract 
levels exist, results at the tract level are more reliable, due to relatively higher statistical 
power in census tracts.223,224  Finally, census tracts have also been shown to be ideal for 
geocoding individuals within their contexts, with approximately 95% accuracy in placing 
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individual within appropriate tracts.226,230  Consequently, for the reasons outlined above, 
NHANES data was linked with ACS and census data at the census tract level. 
Data Linkage 
Individuals from NHANES were linked with contemporary area-level data using 
census tract identifiers For example, 1999-2000 NHANES data were linked with 2000 
Decennial Census data via 2000 census tract identifiers, and 2011-2012 NHANES data 
were linked with 2009-2013 ACS data via 2010 census tract identifiers (Figure 1). 
Linking NHANES data with contemporary area-level data was beneficial in that 
individuals were placed in their relevant social context. 
Cardiometabolic Biomarkers 
All biospecimen were obtained by trained technicians during the MEC.  
Glucose Metabolism: A single measurement of glycosylated hemoglobin, representing 
the average blood glucose level over approximately three months, was assessed with a 
high performance liquid chromatography analyzer.231  
Blood Pressure: systolic and diastolic blood pressure (mmHg) were assessed up to three 
times with a mercury sphygmomanometer according to standards of the American Heart 
Association.231 When multiple measurements were available (n= 10266; 98%), they were 
averaged to obtain mean systolic and diastolic blood pressure. Z-scores based on age, 
gender, and height were calculated using the following formula:87 
Zsbp = (X - µ)/σ 
  X: Observed value 
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𝜇: Expected value based on age, gender, height 
  𝜎: Gender − specific standard deviation (Male: 10.7128, Female: 
10.4855)87 
Lipid Metabolism: Two measures of lipid metabolism were used: 1) HDL Cholesterol 
(mg/dL) levels are analyzed using an endpoint reaction technique specific for HDL 
cholesterol.231 2) Total cholesterol (mg/dL) levels are analyzed using a single-reagent 
endpoint technique specific for cholesterol.231 Previous analyses of cardiometabolic risk 
have utilized triglycerides instead of total cholesterol, in an attempt to diagnose 
Metabolic Syndrome.25,30 As the aim of this study is to examine pre-clinical indicators of 
disease, the use of total cholesterol is appropriate as total cholesterol tracks better over 
time compared to other biomarkers of lipid metabolism.232 Additionally, using 
triglycerides would have reduced the sample size by 51.8 percent (n= 5019), limiting 
hierarchical analyses due to a potentially small number of individuals residing in each 
census tract.233  
Adiposity: Waist circumference (cm) is measured by a trained health technician.231   
Index of Cardiometabolic Risk  
We created a continuous index of cardiometabolic risk by summing z-scores for 
glycosylated hemoglobin levels, 234–236 waist circumference,14 and HDL cholesterol and 
total cholesterol,57,58,234 and for systolic and diastolic blood pressure.17–19 All z-scores 
were age and gender specific, except the z-score for blood pressure which was based on 
age, gender, and height.87  Higher scores indicate higher risk (HDL was multiplied by -1).  
Parametrization of this cardiometabolic index was informed by evidence indicating a 
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multivariate measure better predicts future development of disease than any individual 
biomarker alone.61 Additionally, a continuous measure reflects population-level variation 
in cardiometabolic risk237,238 and, thus, better predicts adult health compared with a 
categorical measure.239  A related point is that false positive and false negative errors may 
arise when categorical measures are used.  Finally, a continuous measure allows more 
statistical power, an important consideration given that prevalence of high 
cardiometabolic risk during adolescence may be only 4% (depending on the definition 
used).3,237  
Individual-level Variables - Figure 2 identifies variables that have been linked with 
cardiometabolic risk in previous studies, and which variables have been included for this 
study.  
Survey Wave – Indicator variables for waves of NHANES data were included to account 
for potential period effects. Survey wave was coded as 1/0, with 1 indicating wave of 
data. This is included in the Demographic Variables and Sample Weights file from 
NHANES. 
Age – Age in years is reported as a continuous variable (parental/guardian report for 
individuals <16 years of age). This was collected during the Household Interview portion 
of data collection.  
Gender – Gender is reported as a categorical variable: Male, Female. Gender was dummy 
coded as 1/0 with 1 indicating female (parental/guardian report for individuals <16 years 
of age). This was collected during the Household Interview portion of data collection. 
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Race/ethnicity – Race/ethnicity is reported as a categorical variable: non-Hispanic White, 
Non-Hispanic Black, Non-Hispanic Asian, Mexican American, Other Hispanic, and 
Other Race/Ethnicity Non-Hispanic  (parental/guardian report for individuals <16 years 
of age). Non-Hispanic Asian, Other Hispanic and Other race/ethnicity were grouped 
together as “Other.” Because the group of participants identified as belonging to “other” 
races/ethnicities is small and heterogeneous, race-specific regression results are not 
presented for this group, although they were included in the analytic sample and overall 
results. Race/ethnicity was coded as 1/0, with 1 indicating belonging to that racial/ethnic 
group. This was collected during the Household Interview portion of data collection. 
Cotinine Levels – Cotinine (ng/mL) is a metabolite of nicotine exposure. Cotinine is 
collected via blood sample from the participant as part of the Mobile Examination Center. 
This is collected for participants aged 3 years and above, and was measured using an 
isotope dilution-high performance liquid chromatography/atmospheric pressure chemical 
ionization tandem mass spectrometry.231  Cotinine was kept as continuous. 
Physical Activity – Self-reported “Over the past 30 days, did you do moderate activities 
for at least 10 minutes that cause only light sweating or a slight to moderate increase in 
breathing or heart rate? Some examples are brisk walking, bicycling for pleasure, gold, 
and dancing.” This is reported as a categorical variable: Yes, No, Unable to do activity, 
Refused, Don’t know. This was coded as 1/0 with 1 indicating any physical activity. For 
individuals aged 12 to 15 years, this was asked during an interview at the Mobile 
Examination Center. Individuals aged 16 to 19 years were asked this question during 
Home Interview portion of data collection.  
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Hypertension Status – For individuals over >= 16 years of age, a self-reported diagnosis 
of hypertension, “Have you ever been told by a doctor or other health professional that 
you had hypertension, also called high blood pressure?” is reported as a categorical 
variable: Yes, No, Refused, Don’t Know. Hypertension status was coded as 1/0 with 1 
indicating a previous hypertension diagnosis. Refused and Don’t Know was treated as 
missing. This was collected during the Household Interview portion of data collection. 
Hypertensive using medication – For individuals over >= 16 years of age, a  self-reported 
use of medication to treat hypertension, “Are you now taking prescribed medicine?” is 
reported as a categorical variable: Yes, No, Refused, Don’t Know. This was coded as 1/0 
with 1 indicating taking medication to treat hypertension. Refused and Don’t Know was 
treated as missing. This was collected during the Household Interview portion of data 
collection. 
Diabetes Status – A self-reported previous diagnosis of diabetes (parental/guardian report 
for individuals <16 years of age), “Other than during pregnancy, have you ever been told 
by a doctor or health professional that you have diabetes or sugar diabetes?” is reported 
as a categorical variable: Yes, No, Borderline, Refused, Don’t Know. Diabetes status was 
coded as 1/0 with 1 indicating a previous diabetes diagnosis. Borderline individuals were 
included in the No category for the previous diabetes diagnosis variable. Refused and 
Don’t Know was treated as missing. This was collected during the Household Interview 
portion of data collection.  
Diabetic using insulin – A self-reported use of insulin (parental/guardian report for 
individuals <16 years of age), “Are you now taking insulin?” asked of individuals self-
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reporting as diabetics. Reported as a categorical variable: Yes, No, Refused, Don’t Know. 
This was coded as 1/0 with 1 indicating diabetic taking insulin. This was collected during 
the Household Interview portion of data collection. 
Diabetic using pills – A self-reported use of pills (parental/guardian report for individuals 
<16 years of age), “Are you now taking diabetic pills to lower your blood sugar?” asked 
of individuals self-reporting as diabetics. Reported as a categorical variable: Yes, No, 
Refused, Don’t Know. This variable was coded as 1/0 with 1 indicating diabetic using 
pills to control blood sugars. This was collected during the Household Interview portion 
of data collection. 
Family Poverty Income Ratio (PIR) – PIR represents the ratio of family income to their 
appropriate federal poverty threshold.240 Ratio < 1 indicates a family below the federal 
poverty threshold, while ratios >=1 indicate a family above the federal poverty threshold. 
PIR is reported as a top-coded continuous variable, with all values ≥5 coded 5. This was 
reported by the Household Reference Person during the Household Interview portion of 
data collection. 
Area-level Variables 
Area-level Poverty – The percentage of individuals below the poverty line was used as 
the measure of area-level SES. From Census 2000, the variable is “All individuals for 
whom poverty status is determined – Percent Below Poverty Level.” From 2005-2009 
ACS, the variable is “Population for whom poverty status is determined – Percent Below 
Poverty Level.” From 2009-2013 ACS, the variable is “Population for whom poverty 
status is determined – Percent Below Poverty Level.” This measure is available at the 
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census tract level and is available from decennial Census data and American Community 
Survey data. This is reported in Census and ACS data as a continuous variable. To avoid 
assuming a linear relationship with CM risk, area-level poverty was grouped into 
quartiles for analysis.  Indicator variables for each poverty quartile were created, with 
Quartile 1 (≤ 25th percentile) used as the reference category.  
Percent Non-Hispanic Black Population – Racial/ethnic concentration at the census tract 
level is available from Census 2000, ACS 2005-2009 and ACS 2009-2013 data. The 
percent non-Hispanic Black population at the census tract level was used as a measure of 
racial/ethnic concentration. This is reported as a continuous variable.  
 
Missing Data  
Responses of “Don’t Know,” “Refused,” and “Missing” were treated as missing 
values. Missing values for body mass index, cotinine, and Family PIR were imputed 
using SAS MI PROC MI procedure in SAS 9.3.241 Indicator variables were not imputed, 
as imputed values may fall between 0 and 1, and rounding these values may introduce 
bias. Multiple imputation was carried out using the entire sample in SAS 9.3.241 Multiple 
imputation models used truncated regression with the PROC MI procedure. PROC MI 
produced 10 imputed datasets. Hierarchical linear models for each of the 10 imputed 
datasets were fit using PROC MIXED. PROC MIANALYZE is then used to combine the 
estimates produced from the imputed datasets, and produces 1 set of estimates based on 






1) Descriptive statistics were reported for index of cardiometabolic risk and 
individual cardiometabolic biomarkers by individual-level and area-level covariates. 
The mean and 95% confidence interval were reported.  
 
2)  A model estimating the crude association between area-level poverty and 
cardiometabolic risk was fit to establish a baseline effect of area-level poverty. 
Indicator variables for survey cycle were included at the individual level. Indicator 
variables for area-level poverty quartiles were included on the intercept, with area-level 
poverty quartile 1 (i.e. lowest quartile of area-level poverty) serving as the reference 
category. Regression coefficients, standard errors and 95% confidence intervals were 
reported. 
 
3) Next, a model to determine the effect of area-level poverty, independent of 
individual-level covariates was fit. Race/ethnicity, and family PIR were included in the 
model. Regression coefficients, standard errors and 95% confidence intervals were 
reported. 
 
4) Next, a model to determine the effect of area-level poverty, independent of 
individual-level and area-level covariates was fit. Tract-level percentage non-Hispanic 
black and group mean values for family PIR were added to the intercept. Regression 





5) To determine if the association between area-level poverty and cardiometabolic 
risk differs by race/ethnicity, models in steps 2-4 were fit by racial/ethnic groups: non-
Hispanic White, non-Hispanic Black, Mexican Americans and Other. Regression 
coefficients and 95% confidence intervals were reported (Specific Aim 2). 
 
6) I evaluated exposure to tobacco smoke and physical activity as potential 
mediators of the association between area-level poverty and cardiometabolic 
risk.28,29,243,244  To test mediation, I first fit regression models for each potential 
mediator:245  
a) The net association between area-level poverty and cardiometabolic risk 
without adjusting for mediators. 
b) The association between area-level poverty and the mediator. 
c) The association between the mediator and cardiometabolic risk. 
If significant associations were observed in each of the first three steps, a model was fit 
for the association between area-level poverty and cardiometabolic risk, adjusting for 
the mediator. Partial mediation is considered to exist if both area-level poverty and the 
lifestyle behaviors have a significant association with cardiometabolic risk in the full 
model.  Full mediation occurs if the effect of area-level poverty becomes non-
significant when adjusting for lifestyle behaviors.  
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I examined potential mediators for the overall sample and by race to determine if the 
pathway of area-level poverty to lifestyle behavior to cardiometabolic risk partially 
explains disparities in cardiometabolic risk (Specific Aims 3 & 4). 
In post-hoc analysis, I explored associations between area-level poverty and family PIR, 
and whether these associations differ by race/ethnicity. I compared mean Family PIR by 
area-level poverty for the overall sample, and by race/ethnicity. 
All analysis was conducted in SAS 9.3.241 
Hierarchical Linear Models 
 Hierarchical linear models (HLM) were used to examine the relationship between 
area-level poverty and biomarkers that predict development of future disease among 
adolescents. As this study linked individual-level data (NHANES) and area-level data 
(ACS and Census) with area-level data, HLM allowed for more appropriate statistical 
conclusions than other statistical techniques such as ordinary least squares or logistic 
regression.  
The multistage sampling of NHANES results in selection of individuals based on 
geographic location.211  Therefore, in this analysis, individual-level data are clustered, or 
dependent on the census tract in which residents reside.233,246 A key assumption of 
ordinary least squares and logistic regression is independence of the residuals.  However, 
statistical dependency, that occurs when individuals are nested within a census tract, 
violates this assumption and leads to negatively biased standard errors and thus a greater 
likelihood of Type I error.233,246  
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Statistical dependency of multilevel data also suggests that covariance of the 
outcome variable exists within each geographic unit. For example, within a census tract, 
BP of individuals are likely to co-vary. Additionally, variance in the outcome may exist 
between census tracts as the relationship between a predictor variable and the outcome 
variable may differ between census tracts.233,246 Data with statistical dependency (e.g. 
survey data, multilevel data) is often analyzed with general estimating equations in order 
to properly estimate variance. However, in general estimating equations, variance is 
controlled for, and not explicitly examined. Without partitioning variance into within- 
and between-tract components, it is difficult to understand total variability in the 
outcome. 
HLM provides an error term for both the individual- and area-level models, 
allowing variance to be partitioned into within- and between-unit components. HLM 
accounts for statistical dependency by assigning one statistical model to the individual-
level and one statistical model to the area-level. Standard errors are estimated for 
parameter estimates at both the individual- and area-level; this produces unbiased 
standard error estimates, allowing for more appropriate statistical conclusions.233,246 
As this study aims to understand the relationship between area-level poverty and 
cardiometabolic risk among adolescents (independent of individual- and area-level 
covariates), a random intercept model with fixed slopes is appropriate. This type of 
model allows for area-level predictors (e.g. area-level poverty) and confounders (e.g. 
racial/ethnic concentration) to be included, as well as individual-level covariates. The 
intercept (average outcome within each census tract) varies as a condition of the area-
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level poverty within each census tract, while the slope (effect of individual-level 
covariates) is constant across census tracts. 
 
Linear Regression Model Components 
The following describes the hierarchical linear regression model, with random 
intercepts, using the cardiometabolic index as the outcome.  
 
𝐶𝑀𝐼𝑖𝑗: Cardiometabolic Index of Individual 𝑖 in census tract 𝑗 
Area-level Poverty: Poverty rate quartiles of census tract j  
Racial ConcentrationCentered = (Racial Concentrationj – X Racial Concentration..) : 
Percent non-Hispanic Black of census tract j grand mean centered 
 
Level 1 Components 
𝛽0𝑗: Intercept (Average outcome when all covariates at the mean, and all dummy 





]: Vector of individual-level coefficients 
[𝑋2𝑖𝑗 … 𝑋𝑛𝑖𝑗]: Matrix of individual − level covariates (n= number of covariates) 
𝑟𝑖𝑗: Individual − level residual   
 
Level 2 components 
𝛾00 ∶ Intercept  (Average outcome when all covariates at mean, and all dummy 
variables are at 0) 
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𝛾01 … 𝛾03(𝐴𝑟𝑒𝑎 − 𝑙𝑒𝑣𝑒𝑙 𝑝𝑜𝑣𝑒𝑟𝑡𝑦 𝑄𝑢𝑎𝑟𝑡𝑖𝑙𝑒𝑠): Effect of Area-level Poverty 
quartile of unit  j on the intercept (average effect of area-level poverty) 
𝛾04(𝑅𝑎𝑐𝑖𝑎𝑙 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛𝐶𝑒𝑛𝑡𝑒𝑟𝑒𝑑) = ∶ Effect of Racial Concentration of unit  j 






]: Coefficient for Level-1 covariates (effect of individual-level covariates on 
𝐶𝑀𝐼𝑖𝑗) 
𝑢0𝑗: Area − level residual  
 
Hierarchical Model 




] [𝑋1𝑖𝑗 … 𝑋𝑛𝑖𝑗] + 𝑟𝑖𝑗 












𝐶𝑀𝐼𝑖𝑗 =  𝛾𝑜𝑜 + [𝛾01(𝑄2 𝐴𝑟𝑒𝑎 − 𝑙𝑒𝑣𝑒𝑙 𝑃𝑜𝑣𝑒𝑟𝑡𝑦𝑗) +  𝛾02(𝑄3 𝐴𝑟𝑒𝑎 − 𝑙𝑒𝑣𝑒𝑙 𝑃𝑜𝑣𝑒𝑟𝑡𝑦𝑗)










All individual-level variables were group mean centered (centered on the mean 
value for the census tract), excluding the dichotomous variables. The group mean of all 
individual-level group mean centered variables was included at the area-level. Area-level 
variables were grand mean centered.  
This method of centering is preferred when testing “2-1-1” mediation, in that an 
individual-level variable is the potential mediator between an area-level exposure and an 
individual-level outcome.245 By centering individual-level variables at the group mean 
and including the group mean at the area-level, the relationship between the potential 
mediator (i.e. cotinine, physical activity) and the outcome (i.e. cardiometabolic index) is 
decomposed into within-tract and between-tract components. Decomposing the 
relationship is important for two reasons: First, mediation can occur both within and 
between tracts. Secondly, the effect of the area-level group mean variable on the outcome 
may be different than the effect of the group-mean centered individual-level variable.245 
This may help identify three distinct types of mediation. First, mediation could mainly 
occur between tracts, and the relationship between the mediator and outcome within 
tracts may be weak. Second, mediation could mainly occur within tracts, and the 
relationship between the mediator and outcome between tracts may be weak. Third, there 
may be a moderately strong relationship between the mediator and the outcome both 
within and between tracts. These distinct types of mediation would be confounded under 
grand-mean centering or no centering of the individual-level variables, as the individual -





Weights were utilized in NHANES data to account for the complex sample design 
of NHANES data, and survey non-response. Using these weights are important, as 
analyses without weights will likely result in biased estimates and inaccurate significance 
levels. Additionally, use of weights allows for generalizations about the United States 
non-institutionalized population between 1999 and 2012. 
NHANES data also includes various weights for analysis. For example, weights 
are provided for the in-home interview data from NHANES, and separate weights are 
available for the clinical and biomarker data. It is recommended that the weight for the 
smallest subpopulation that includes all variables in analysis be used. The analysis 
includes data collected during the in-home interview (e.g. age, race/ethnicity) and data 
collected at the Mobile Exam Centers. Due to this, the Mobile Exam Center weight was 
used, because the Mobile Exam Center population represents the smallest subpopulation 
represented in the data. When combining 14 years of data, a 14-year weight was 
constructed. This 14-year weight consists of a 4-year weight from the 1999-2002 waves 
of NHANES, and 2-year weights from each of the waves from 2003-2012. SAS code 
used to construct this 14 Year Weight is in Appendix C.1.247 
 As this study uses hierarchical models, sampling weights were scaled to the 
census tract level. Scaling weights is suggested as it better allows for investigations of 
variance between and within clusters.248 It is recommended to use two methods of 
scaling, and compare results. With Method A, weights are scaled so that the new weights 
sum to the cluster sample size.248 This method may provide smaller standard error 
estimates if interested in reporting point estimates, and may be more appropriate with a 
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large number of Level 2 units. With Method B, weights are scaled so that the new 
weights sum to the effective cluster size.248 This method may be more appropriate if 
discussion of variance-covariance is of greater importance. Models were initially fit with 
Method A scaled weight, as point estimates are of interest, and there are a large number 
of Level 2 units (n= 3140). Models were fit with 14 Year MEC Weight and Method B 
scaled weight. Estimates and standard errors across weighting methods were compared to 
determine which method provides the most precise estimates.248 The recommended SAS 
code is in Appendix C.2.248 
 
Linearity  
In this study, the relationship between the continuous predictor variables and the 
outcome variables is assumed to be a linear relationship. This was assessed by plotting 
the residuals against predictor variables. If the likelihood of linearity is low, this may be 
addressed by transforming the predictor variables. The type of transformation performed 
depends on the relationship observed between the predictor and the outcome. 
 
Assumptions of Hierarchical Linear Regression 
 The following assumptions of hierarchical linear models were tested233: 
1. Individual-level 𝑟𝑖𝑗 are independent and normally distributed with a mean of 0 
and variance for every individual within each census tract.  
a. This was tested by obtaining a Q-Q Plot of the Level-1 residuals. 




2. The individual-level predictors [𝑋1𝑖𝑗 … 𝑋𝑛𝑖𝑗] are independent of 𝑟𝑖𝑗 . 
a. This was tested by plotting the individual-level residuals against the 
individual-level predicted values. 
3. Area-level 𝑢′𝑠  are multivariate normal, each with a mean of 0, some variance 
and covariance. 𝑢′𝑠 are independent among the area-level units. 
a. This was tested by obtaining a Q-Q Plot of the area-level residuals. 
Homogeneity of variance was tested by plotting frequencies of area-level 
variances. 
4. The set of area-level predictors are independent of every 𝑢. 
a. This was tested by plotting the area-level residuals against the area-level 
predicted values.  
5. The individual-level errors and area-level errors are independent of one another. 
a. This was tested by plotting the individual-level residuals against area-level 
residuals. 
6. The predictors at each level are independent of the residuals at the other level. 









Chapter VII. Results 
Descriptive Statistics  
The analytic sample includes 10,415 adolescents and 3140 census tracts, resulting in 3.34 
adolescents per tract, on average.  Descriptive statistics appear in Table 1. Mean area-
level poverty across census tracts is 14.46 percent (interquartile range 6.1, 19.8), and 
mean percent non-Hispanic Black population is 12.90 percent (interquartile range: .58, 
12.84).  
Mean score on the index of cardiometabolic risk for the total sample is -.810 
(95% CI: -.884, -.737). Residents in the fourth quartile of area-level poverty (highest 
area-level poverty) had the highest average cardiometabolic risk score (-.535, 95% CI: -
.669, -.371), followed by third (-.531, 95% CI: -.694, -.367), second (-.855, 95% CI: -
.984, -.726), and first quartiles (-1.048, 95% CI: -1.182, -.915). Differences in mean 
cardiometabolic risk were observed by race. Non-Hispanic blacks have highest average 
cardiometabolic risk score (-.643, 95% CI: -.759, -.526), followed by Mexican Americans 
(mean: -.692, 95% CI: -.817, -.567), and non-Hispanic Whites (-.855, 95% CI:-.963, -
.747). 
Hierarchical Linear Model Results 
Table 2 includes results of hierarchical models estimating the association between 
area-level poverty and the index of cardiometabolic risk. In the crude model (model 1), 
increasing area-level poverty is associated with increasing cardiometabolic risk scores, 
and this pattern is independent of individual-level covariates (model 2) as well as racial 
concentration (model 3).  In the fully adjusted model, relative to the first quartile of area-
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level poverty, residents of the second, third, and fourth quartiles of area-level poverty 
experienced .218 (95% CI: .012, .424), .438 (95% CI: .213, .665), and .451 (95% CI: 
.204, .698) elevated cardiometabolic risk scores, respectively (Figure 3).   
Of note is inclusion of individual-level covariates (model 2) reduced the 
coefficients of the second, third, and fourth quartiles of area-level poverty by 19.6%, 
18.2%, and 22.2%, respectively, yet all remain statistically significant.  This suggests 
individual-level covariates partially explain the association between area-level poverty 
and cardiometabolic risk. In contrast, when including area-level racial concentration in 
the model (Model 3), the coefficients for the quartiles of area-level poverty increased by 
1.8%, 2.5%, and 4.8%, respectively, when compared to Model 2.  This suggests that the 
association between area-level poverty and cardiometabolic risk is not explained by 
concentration of racial minorities. 
Model Fit 
Log likelihood ratio tests for the overall sample suggest including additional 
individual-level variables in Model 2 did not improve model fit compared to Model 1 (x2: 
2.49 df=5 p=.778). Compared to Model 2, addition of area-level covariates in Model 3 
improved model fit (x2: 10.48 df=1 p=.001). Compared to Model 1, the full model 
improved model fit (x2: 12.97 df=6 p=.043). 
Race/Ethnicity Specific Analysis  
In race/ethnicity specific analyses (Table 2), area-level poverty is associated with 
cardiometabolic risk among non-Hispanic Whites and Mexican Americans, but not 
among non-Hispanic Blacks.   
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Mediation Analyses  
We did not find any evidence of mediation by exposure to tobacco smoke (Table 
3) and physical activity (Table 4) for the full sample or by race/ethnicity.   
Post-hoc analysis  
In post-hoc analysis, we explored associations between area-level poverty and 
family poverty-to-income ratio (PIR), and whether these associations differ by 
race/ethnicity (Table 5). Overall, mean family PIR declined from 3.34 in quartile 1 to 
1.42 in quartile 4 (p< .001). Within each racial/ethnic group, mean family PIR declined 
across area-level poverty quartiles. However, the magnitude of this difference varied by 
race/ethnicity.  Between the first and fourth quartiles, non-Hispanic Whites had a 1.93 
unit decline (p<.001), non-Hispanic Blacks had a 1.27 unit decline (p<.001), and 
Mexican Americans experienced a 1.22 unit decline (p<.001). 
Within each quartile of area-level poverty, racial/ethnic differences in mean 
family PIR are attenuated as area-level poverty increases.  For example, in quartile 1, 
mean family PIR for non-Hispanic whites is .92 units higher than mean family PIR for 
non-Hispanic blacks, and this difference is only .26 in quartile 4 (Table 5).  
Variance Components  
Variance components for overall models and models by race/ethnicity are 
included in Table 2. Total variance explained (τ00  + σ2 = 5.93) does not differ across 
models for the overall sample. The intraclass correlation does not change across models 
for the overall sample, as approximately 25 percent of the variance in cardiometabolic 
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risk is found between tracts and approximately 75 percent of the variance is found within 
tracts.  
Comparison of model weights  
 
Table 6 includes area-level results of full models weighted with scaling method 
A, scaling method B, and MEC 14 year weights. Models were initially fit with method A 
scaled weights. In models using method A scaled weights, coefficient estimates and 
standard errors of the second, third, and fourth quartiles of area-level poverty were .218 
(se: .105), .438 (se:.115), and .451 (se:.126), respectively. Method B scaled weights 
coefficient estimates and standard errors of the second, third, and fourth quartiles of area-
level poverty were .229 (se:.107), .454 (se:.117), and .466 (se:.128), respectively. 
Compared to method A scaled weight results, method B scaled weight results in a 3 to 5 
percent increase in coefficient estimates, and a 2 percent increase in standard errors. 
Using MEC 14 year weights, results of the second, third, and fourth quartiles of area-
level poverty were .218 (se: .105), .443 (se:.120), and .459 (se:.136), respectively. 
Compared to method A scaled weight results, MEC 14 year weight results in no change 
for the second quartile, and an approximately 1 percent increase in coefficient estimates 
and 4 to 7 percent increase in standard errors. 
 
Assumptions of Hierarchical Linear Regression  
The six assumptions for hierarchical linear regression were tested for the overall 
model as outlined in the methods section. Plots for each assumption are in Figure 4. 
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For assumption 1, a Q-Q plot and a histogram of individual-level residuals were 
obtained to observe distribution of individual-level residuals. Initial results suggest the 
individual-level residuals are not normally distributed (Figure 4a). Outliers (observations 
with individual-level residuals ≥ 14) were deleted, and this improved the distribution of 
individual-level residuals (Figure 4b). To test independence of individual-level residuals, 
residuals were plotted against predicted values for both the initial model, and model with 
deleted observations (Figure 4c). The independence assumption was violated in both the 
initial model and the model with deleted observations. Inclusion of physical activity and 
cotinine at the individual level, and percent of female-headed households and percent of 
individuals receiving public assistance at the area-level did not result in independence of 
individual-level residuals (Figure 4d). Homogeneity of variance was tested with Levene’s 
test of homogeneity. Homogeneity of variance was violated for the initial model (F=1.45, 
p<.001) and for the model with deleted observations (F=1.45, p<.001).  
For assumption 2, the individual-level residuals were plotted against all 
individual-level predictor variables, and results suggest assumption 2 has been met 
(Figures 3e - 3f).  
For assumption 3 a Q-Q plot and a histogram of area-level residuals were 
obtained to observe distribution of area-level residuals. Initial results suggest the area-
level residuals are not normally distributed (Figure 4g). Outliers were deleted, and this 
improved the distribution of area-level residuals (Figure 4h). To test the independence of 
area-level residuals, residuals were plotted against the predicted value of the intercept. 
The independence of area-level residuals was met in the initial model, and in the model 
with deleted observations (Figure 4i). 
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For assumption 4, the area-level residuals were plotted against all area-level 
predicted values, and the results suggest assumption 4 has been met (Figure 4j).  
For assumption 5, the individual-level residuals were plotted against the area-
level residuals, and results suggest an association (Figure 4k). In an attempt to address 
this violation of assumption 5, additional area-level predictors of percent of female-
headed households and percent of individuals receiving public assistance were added to 
the model, yet the association between individual- and area level residuals remained 
(Figure 4k). Additionally, the association between individual- and are-level residuals 
remained after the addition of interactions between area-level poverty and racial 
concentration were added to the model to the model (Figure 4k).  
For assumption 6, individual-level residuals were plotted against area-level 
predictors, and area-level residuals were plotted against individual-level predictors, with 













Chapter VIII. Discussion 
In this examination of the association between area-level poverty and 
cardiometabolic risk among a nationally representative sample of U.S. adolescents, we 
found that among US adolescents there is a dose-response association between area-level 
poverty and cardiometabolic risk. Moreover, this was the first study to identify important 
distinctions by race/ethnicity.  
Area-level poverty is associated with cardiometabolic risk among non-Hispanic 
whites and Mexican Americans but not among non-Hispanic blacks. Notably, among 
non-Hispanic whites and Mexican Americans, a non-linear association was observed as 
the effect of residence in quartile 4 of area-level poverty was not larger than the effect of 
residence in quartile 3 of area-level poverty. This suggests that while exposure to high 
levels of area-level poverty has negative consequences on cardiometabolic risk, the dose-
response effect plateaus within quartiles 3 and 4 of area-level poverty. Additionally, there 
may be few non-Hispanic whites and Mexican Americans residing in quartile 4 of area-
level poverty, resulting in more unstable estimates. This possibility is supported by the 
wider confidence intervals for the estimates of quartile 4 of area-level poverty for both 
non-Hispanic whites and Mexican Americans. 
Among our sample, the association between area-level poverty and 
cardiometabolic risk was similar for both non-Hispanic whites and Mexican Americans. 
Additionally, post-hoc analysis suggests non-Hispanic whites have a higher average 
family PIR than Mexican Americans (Table 5). Taken together, these observations are 
accordant with literature on the Hispanic paradox. The Hispanic paradox suggests that in 
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the United States, despite generally lower socioeconomic status among Hispanic 
populations, they have similar or better outcomes to non-Hispanic whites.249,250 
In contrast, among non-Hispanic blacks, area-level poverty was independent of 
cardiometabolic risk. These findings are in line with previous work which observed a 
greater gradient in the association between individual-level SES and health among non-
Hispanic whites than other racial/ethnic groups.251–254 The improvement in health-related 
outcomes associated with higher SES appears to be greater for non-Hispanic whites than 
for other racial/ethnic groups. Additionally, evidence suggests non-Hispanic blacks 
experience greater levels of social adversity across all levels of socioeconomic status,254 
and the experience of social adversity is an under-addressed determinant of health.254,255 
This suggests when examining the role of area-level poverty in racial/ethnic disparities in 
health, the individual-level experience of individuals within a particular socioeconomic 
group (i.e. residence in a specific quartile of area-level poverty), and not solely their 
membership within that particular socioeconomic group, is an important determinant of 
health. 
Racial/ethnic differences in cardiometabolic risk scores were observed, as non-
Hispanic blacks have the highest cardiometabolic risk score (Table 1). The observed 
racial/ethnic disparities in cardiometabolic risk differed from the racial/ethnic disparities 
reported in previous literature.3,4,25–30   The differences in reported racial/ethnic disparities 
in cardiometabolic risk are likely due to biomarker-specific racial/ethnic differences for 
lipid metabolism and glucose metabolism (Table 1). Among biomarkers for lipid 
metabolism, non-Hispanic whites have lowest average levels of HDL cholesterol, and 
there are no racial/ethnic differences in total cholesterol levels. For glucose metabolism, 
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non-Hispanic blacks have highest average levels of HbA1c. These racial/ethnic 
differences among specific biomarkers are in line with extant literature.4,25,27 
Additionally, the observed racial/ethnic disparities in cardiometabolic risk in the current 
study is consistent with studies among adults suggesting non-Hispanic blacks have higher 
prevalence of cardiometabolic diseases in adulthood.24  
The estimated degree of racial/ethnic disparities in cardiometabolic risk can 
depend, in part, on the choice of biomarkers used to measure lipid metabolism and 
glucose metabolism.  This is because the biomarkers that can be used to assess lipid 
metabolism and glucose metabolism  yield distinct cardiometabolic risk profiles.4,25,27  
For example, among biomarkers of lipid metabolism, non-Hispanic whites consistently 
have lower HDL cholesterol and triglycerides than both non-Hispanics and Mexican 
Americans, while there are no differences by race/ethnicity in total cholesterol 
levels.4,25,27  Among biomarkers of glucose metabolism, non-Hispanic whites have fasting 
glucose levels that are similar to that of Mexican-Americans and higher than fasting 
glucose levels observed among non-Hispanic blacks.4,25,27  However, when examining 
Hba1c levels, non-Hispanic blacks have a three-fold higher prevalence of elevated Hba1c 
than both non-Hispanic whites and Mexican Americans.27  
In turn, these differences are reflected in the performance of indices of 
cardiometabolic risk. For example, when fasting glucose and triglycerides were included 
in an index of cardiometabolic risk among a nationally representative sample of US 
adolescents,30 Hispanics had the highest cardiometabolic risk, followed by non-Hispanic 
whites and non-Hispanic blacks, respectively.30 In contrast, for the current study, we used 
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glycosylated hemoglobin and total cholesterol in our index of cardiometabolic risk, and 
found non-Hispanic blacks to have the highest cardiometabolic risk. 
Our choice of biomarkers was informed by evidence that total cholesterol tracks 
better over time compared to other biomarkers of lipid metabolism,232 and availability of 
total cholesterol measures in NHANES allows for sufficient sample size for analyses. 
Similarly, HbA1c represents a three-month average of glucose metabolism tracks over 
time, thus is a more stable indicator of glucose metabolism than fasting glucose tests as it 
is less influenced by recent diet or illness.236,256,257 Thus, for the purposes of our study, 
total cholesterol and HbA1c are appropriate biomarkers for use in our index of 
cardiometabolic risk. Furthermore, the racial/ethnic disparities observed in the current 
study are similar to racial/ethnic disparities in cardiometabolic health among adults,24 
suggesting our parameterization of cardiometabolic risk is consistent with findings from 
previous studies. 
Post hoc analysis was conducted to determine if the economic experience of 
residing in areas with high poverty differed by race/ethnicity. We explored associations 
between area-level poverty and family PIR, and whether these associations differ by 
race/ethnicity.  Across the range of area-level poverty quartiles, non-Hispanic whites 
have greater variability in their family-level economic conditions than non-Hispanic 
blacks and Mexican Americans. More specifically, with lower area-level poverty, there is 
a more pronounced increase in family PIR among non-Hispanic whites than among non-
Hispanic blacks and Mexican Americans. Additionally, within quartiles of area-level 
poverty, the differences in mean family PIR between racial/ethnic groups are attenuated 
as area-level poverty increases. This suggests that at higher levels of area-level poverty, 
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the economic experience of non-Hispanic whites is more similar to that of non-Hispanic 
blacks and Mexican Americans. Racial/ethnic differences in the associations between 
area-level poverty and cardiometabolic risk may be related to the different relationships 
between area-level poverty and family-level SES by race/ethnicity. 
Discrimination and health 
Discrimination, manifest as both an individual- and area-level stressor, is a key 
determinant of racial/ethnic disparities in health,258–261  thus, discrimination may partially 
explain racial/ethnic disparities in cardiometabolic risk observed in this study. 
Race is a social construct, which individuals are grouped into social strata based 
on phenotype.260  In race-conscious societies, like the United States, social advantages 
(e.g. educational and employment opportunities, access to resources, political 
participation, etc.) are distributed based on these strata.260–262  Discrimination, which is 
premised on this distribution of advantages, is a system in which the advantages are 
differentially allocated towards a racial group in power, and away from other racial 
groups.261 Historically, in the United States, social advantages are allocated towards the 
white population, and allocated away from other racial groups as a means of maintaining 
power.260–262 
At the individual level, discrimination includes intentional and unintentional 
actions that manifest itself as, yet are not limited to, lack of respect, devaluation, 
dehumanization, and oppression.260,263–266 One hypothesis on the link between 
discrimination at the individual level and disparities in cardiometabolic health is John 
Henryism.267 This hypothesis states that individuals exposed to discrimination (a stressor) 
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exert more energy to respond to consequences associated with exposure to stress (as 
detailed in Chapter V). However, not all individuals respond the same way, as some 
individuals may have a greater physiologic reaction to discrimination than others.267  
Furthermore, under this hypothesis, individuals that jointly are of low SES and react 
more actively to discrimination will experience worse cardiometabolic health as a 
result.267   
More related to the current study, discrimination at the area-level, referred to as 
structural discrimination, operates independently of individual-level discrimination.268  
Structural discrimination (including but not limited to racial segregation, low level of 
political participation among racial minorities, poor judicial treatment of racial 
minorities) is the result of laws, policies, and political infrastructures at the federal, state, 
and local levels, aimed to protect advantages of Whites while denying advantages to 
other racial groups in the United States.260,269–271  Resource Deprivation Theory267  
hypothesizes that structural discrimination  is associated with racial/ethnic disparities in 
cardiometabolic health, as racial/ethnic minorities in the United States are less likely to 
reside in areas with the necessary infrastructure to promote good cardiometabolic 
health.267   The lack of access to resources is a source of stress, and is associated with a 
lack of healthy food options and lack of access to medical care.267  
Individual-level discrimination and cardiometabolic health 
Recent evidence among non-Hispanic black adolescents (n = 47) suggests 
perceived discrimination (i.e. treated with less respect, poor service at restaurants), an 
individual-level stressor, is associated with increased cardiometabolic risk.263 This aligns 
60 
 
with a more substantial body of evidence among adults suggesting perceived 
discrimination is associated with cardiometabolic health.264,272–276 Among a small sample 
of U.S. adults (n=176), evidence suggests perceived discrimination lies on the pathway 
between race/ethnicity and disparities in cardiometabolic risk.264 
Structural discrimination and cardiometabolic health 
The Resource Deprivation Theory aligns with evidence of racial segregation, the 
forced residence of certain racial groups into specific areas, as a fundamental social 
determinant of racial/ethnic disparities in health.258,259 Racial segregation is associated 
with racial differences in educational and employment opportunities, thus, is a key factor 
in racial differences in SES in the United States. 258,259 These racial differences in SES 
lead to areas with high levels of poverty, a reduction in the tax base in segregated areas, 
and a lack of services which promote good health.258,259 Racial segregation is associated 
with racial disparities in cardiometabolic  health among adults,277–279 and recent evidence 
suggests a link between racial segregation and cardiometabolic risk among children and 
adolescents.280,281  
While state-level measures of structural discrimination (i.e. ratio of blacks versus 
whites in terms of political participation, employment and job status, educational 
attainment, and judicial treatment) are understudied, a nationally-representative study 
among adults (n = 32752) observed that blacks residing in states with a high degree of 
structural discrimination against blacks had higher risk of cardiometabolic disease 
compared to blacks residing in states with a low degree of structural discrimination 
against blacks.269 Among whites, those residing in states with a high degree of structural 
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discrimination against blacks  had lower risk for cardiometabolic disease than whites 
residing in states with a low degree of structural discrimination against blacks.269  
As the focus on this study is on the association between area-level poverty at the 
census tract level and cardiometabolic risk among adolescents, exposure to 
discrimination was not accounted for in this study. Variables representing perceived 
discrimination are not available in NHANES data, thus, exposure to discrimination at the 
individual level cannot be accounted for in this study. At the area level, racial 
concentration (a crude measure of racial segregation) was accounted for in analysis. 
However, evidence suggests racial segregation is best measured at larger geographies, 
(i.e. Metropolitan Statistical Areas, cities, or counties)258,277–279 as measures of racial 
segregation will then depict a more racially and geographically diverse population, 
allowing for a better understanding of how different racial groups are distributed. 
Mediation Analysis 
The lack of association observed between cotinine levels and cardiometabolic risk 
may be due to the use of linear models, and mixing of effects. As the aim of this study is 
to examine pre-clinical indicators of disease, the linear association between cotinine 
levels and cardiometabolic risk was tested, yet a lack of association was observed. This 
differs from prior studies, which observed an association between cotinine levels and 
cardiometabolic risk among adolescents when using a diagnostic approach when 
measuring cardiometabolic risk.29 Furthermore, the association between cotinine levels 
and cardiometabolic risk may be biomarker specific.282–285 Evidence suggests cotinine 
levels are associated with glucose metabolism,282 adiposity,285 and blood pressure.283 
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However, among nationally representative sample, cotinine levels were not associated 
with cholesterol levels.284 The lack of association observed between cotinine levels and 
cardiometabolic risk in this study may be due to a mixing of effects, as the index of 
cardiometabolic risk incorporates multiple biomarkers of cardiometabolic risk.  
The physical activity variable used in mediation analysis is self-reported, thus, 
measurement error and self-report bias are inherent. Social desirability may have 
contributed to individuals reporting more frequent or intense physical activity than was 
actual. This introduces measurement error, thus lowering the reliability of the data. Less 
reliable data increases the chance of observing a nonsignificant association when a 
significant association is true, and lowers the strength of association. Also, the question 
asked of physical activity was, “Over the past 30 days, did you do moderate activities for 
at least 10 minutes that cause only light sweating or a slight to moderate increase in 
breathing or heart rate? Some examples are brisk walking, bicycling for pleasure, gold, 
and dancing.” This suggests individuals with only one 10-minute period of physical 
activity in the past 30 days are included in the same category as individuals with much 
more frequent and intense physical activity. Thus, this categorical variable doesn’t 
represent this potentially wide variability of physical activity in the sample, which may 
contribute to the lack of association between physical activity and cardiometabolic risk 
observed in this study.  
Comparison of weighting method  
Results suggest that the coefficient estimates for the association between area-
level poverty and cardiometabolic risk does not significantly differ based on weighting 
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method. Additionally, the standard errors for Method A scaled weights are the smallest, 
yet do not significantly differ from standard errors for Method B scaled weights for MEC 
14 year weights. As coefficient estimates and standard errors do not significant differ 
across weighting methods, this increases confidence in the observed association between 
area-level poverty and cardiometabolic risk.247 Based on our interest in reporting point 
estimates, the large number of census tracts in analysis, convergent results across 
weighting methods, and the smallest standard errors for Method A scaled weights, results 
from Method A scaled weights are most appropriate to report. All models in Table 2 were 
weighted using Method A scaled weights. 
Assumptions of Hierarchical Linear Regression  
As assumptions 2, 4, and 6 were initially met, this suggests there are no errors in 
the estimates for the fixed effects. As the primary purpose of this study is to examine the 
association between area-level poverty and cardiometabolic risk, a lack of errors in the 
fixed effects increases confidence in the results reported in Table 2. As assumptions 1, 3, 
and 5 were violated in the initial model, and attempts to address these violations were 
largely unsuccessful, this suggests model misspecification. Models presented here could 
be under specified due to the absence of important predictors – at both the individual- and 
area-levels - of cardiometabolic risk not included in the model, known or unknown. Thus, 
the observed regression coefficients may be biased, and may not represent the true 





Strengths and Weaknesses  
These findings should be considered in the context of this study’s strengths and 
weaknesses. This current study adds to the body of evidence on racial disparities in 
cardiometabolic risk among adolescents, and the race-specific associations between area-
level poverty and cardiometabolic risk among adolescents, and improves upon limitations 
in previous work. To date, Theall et al is the only other study to observe an association 
between area-level socioeconomic status and cardiometabolic risk among a national 
representative sample of U.S. adolescents.286 However, the previous study utilized a 
dichotomous outcome to identify individuals with high cardiometabolic risk, did not 
utilize contemporary area-level data, and did not account for area-level covariates, such 
as racial concentration.286  
The use of a continuous measure of cardiometabolic risk better reflects 
population-level variation in cardiometabolic risk237,238 and may be a better predictor of 
adult health.239 It also reduces potential misclassification of an individual’s 
cardiometabolic risk. Our use of contemporary area-level data also minimizes potential 
misclassification of an individual’s area-level poverty due to temporality.  For example, 
for an individual in NHANES 2011-2012, the poverty rate of their census tract of 
residence will be more accurately reflected in ACS 2009-2013 data than in Census 2000 
data. Results from the current study are in line with previous work that area-level racial 
concentration is a unique area-level exposure, and should be considered as an important 
covariate.69–71 Furthermore, by using hierarchical models, parameter estimates and 
standard errors are estimated at both the individual- and area-level, allowing for proper 
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variance estimates that account for the clustered nature of the data, which allows for more 
appropriate statistical conclusions. 
This study is limited by its cross-sectional approach, prohibiting causal 
conclusions. However, findings are in line with prospective studies suggesting exposure 
to high area-level poverty is associated with future disease.43,50–53,55 The modifiable areal 
unit problem  is a potential source of bias when data are aggregated at the area level,287,288  
however, Census 2000 and ACS 5-year estimates are considered the most accurate and 
reliable estimates for smaller geographic areas such as census tracts.289 It should also be 
noted that ACS data has sampling error, while Census 2000 data does not. These 
sampling errors were not included in regression models, which may result in artificially 
smaller standard errors.  
Another limitation relates to the arbitrary geographic boundaries used to define 
contexts. Individuals residing within the arbitrarily defined contexts may not identify 
with those boundaries. Results were interpreted in terms of census tracts, and 
implications and recommendations of the findings should recognize this limitation. 
Results may be subject to residual confounding if important area-level predictors of 








Chapter IX. Implications 
The implications of this study are discussed in this chapter. Interventions should 
target disadvantaged communities, with the aim of improving the area-level economic 
and social conditions residents are exposed to, in order to improve population-level 
health. Individuals with high cardiometabolic risk may be more susceptible to additional 
exposures, and reducing cardiometabolic risk during adolescence may reduce risk for 
poor health outcomes across the life course. 
Implications for Public Health Policy and Practice  
United States health promotion objectives include identifying social determinants 
of racial/ethnic disparities in cardiometabolic disease,2 especially among adolescents15,16 
Results of this study highlight the importance of addressing upstream factors such as 
social determinants of health, (e.g., area-level poverty) in order to reduce cardiometabolic 
risk among adolescents.  
 In order to reduce disparities, policy interventions should target disadvantaged 
communities, identified by indicators of area-level economic and social conditions such 
as area-level poverty.292 Poverty is an economic indicator of area-level disadvantage, and 
relates well to other measures of area-level determinants of health, such as housing 
quality, crime and violence, and the built environment,72–75 and these factors are 
associated with poor health outcomes.293–295 However, area-level economic and social 
conditions of a community are not solely comprised of indicators of disadvantage. 
Indicators of area-level advantage (e.g. civic engagement, social cohesion, existing 
infrastructure) should also be considered, as these exposures (i.e. greater political 
participation by women, high social cohesion) are associated with better health 
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outcomes,296,297 and should be incorporated into interventions aiming to improve the 
health of the population. Community-based participatory research may facilitate a better 
understanding of a given community’s economic and social conditions, allowing 
communities to build upon their unique advantages (e.g. social cohesion, high civic 
engagement) while addressing economic and social disadvantages in order to improve 
population-level health and reduce racial/ethnic disparities. This approach also allows 
residents to take ownership of various policies and programs aiming to improve the area-
level economic and social conditions in which they reside, facilitating the development 
and implementation of geographically, socially, and culturally acceptable solutions to the 
economic, social and population health problems that disadvantaged communities often 
face. 
 As discussed in Chapters II and VIII, social determinants of health, such as area-
level poverty, are related to intertwined historic, social, economic, and political factors 
that, over time, result in differential distribution of resources based on social strata such 
as race/ethnicity or socioeconomic status.298 Thus, no single policy or program 
intervention can sufficiently address the unique area-level economic and social conditions 
disadvantaged communities face. Policymakers, funders, and community members 
should identify a spectrum of policy and program interventions that, in conjunction, aim 
to improve population health. 
Policies targeting disadvantaged communities aiming to improve area-level 
economic and social conditions are in line with recent federal- and state-level efforts. The 
Community Preventive Services Task Force, through systematic review of program 
evaluations, has recommended initiatives aiming to improve health outcomes by 
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addressing area-level economic and social conditions.292 One approach recommended by 
the  Community Preventive Services Task Force are, tenant-based rental assistance 
programs, which typically target low SES or racial/ethnic minority populations to address 
discrimination in housing.299300 These programs  are designed to offer financial assistance 
to low-income families residing in low-SES or segregated areas in order for these 
families to move to areas that are of higher SES or less segregated.299 These interventions 
(e.g., Moving to Opportunity300) have been shown to reduce exposure to crime and social 
disorder, while limited evidence suggests emotional and behavioral health benefits. 300 
Evidence also suggests these programs have similar benefits across racial/ethnic 
populations in the United States. 300 Taking the results of the current study into 
consideration, moving to a lower poverty area may reduce cardiometabolic risk in 
adolescence. Expansion of tenant-based rental assistance programs would give families 
greater control over the economic and social climate they are exposed to, and could be a 
contributing factor in reducing population-level cardiometabolic risk, and reducing 
racial/ethnic disparities in cardiometabolic health.  
Other initiatives aim to improve the area-level economic and social conditions of 
disadvantaged neighborhoods, with the goal of improving living conditions for all 
residents in these communities. These neighborhood revitalization initiatives are often the 
result of citizen groups, local healthcare organizations, or business associations working 
together to address the challenges their communities face. For example, the Dudley Street 
Neighborhood Initiative (DSNI), is a Boston-area resident-led effort formed to address 
intergenerational poverty, a lack of investment, and environmental hazards in a 
historically racially and economically segregated community.301–303 To address a history 
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of discriminatory practices in housing and property ownership in the neighborhood,301–303 
DSNI established a land trust to use vacant lots for affordable housing, while taking an 
anti-displacement approach to housing aiming to limit the potential of residents being 
pushed out due to gentrification.301,302 Current programs include a Promise Neighborhood 
designation (from the U.S. Department of Education and the Boston Promise Initiative), 
in which DSNI is taking a multi-faceted “cradle-to-career” approach, focusing on early 
childhood education, healthy families and career development in order to break the cycle 
of intergenerational poverty in their community.301,302  
Funding organizations, whether governmental or non-governmental, that are 
interested in improving their communities, should provide funding to neighborhood 
revitalization initiatives. Taking an equitable approach to neighborhood revitalization 
initiatives allows disadvantaged communities greater support and funding in order to 
meet their neighborhood revitalization goals and fully achieve their potential. Policy 
makers and community groups should collaborate on multi-faceted neighborhood 
revitalization initiatives promoting equitable opportunities for all citizens in an effort to 
improve population health and reduce racial/ethnic disparities.301 
Tenant-based rental assistance and neighborhood revitalization initiatives aiming 
to improve the area-level economic and social conditions populations are exposed to are 
intermediate- to long-term solutions to improving population health. Targeted 
community-level initiatives can also aim to have a more immediate impact on the health 
of residents. For example, the Community Preventive Services Task Force recommends 
community-wide campaigns to increase physical activity levels.304 Community-wide 
campaigns focused on physical activity typically combine medical-model interventions, 
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such as health screenings, physical activity counseling, and support groups, with 
ecologically focused efforts such as creating and maintaining walking paths and parks.304   
One example of a community-wide campaign is Shape Up Somerville, which 
originated as an attempt to reduce childhood obesity in Somerville, MA.305,306 This 
campaign brought together 25 stakeholder groups to engage the community as a whole, 
including businesses, government, schools, and citizen groups.305,306  Shape Up 
Somerville included providing healthier food options at local restaurants and at school, 
retraining clinicians and school nurses to identify and address childhood obesity, and 
expanding and renovating parks in Somerville.305,306Within the first school year after 
Shape Up Somerville was implemented (2003-2004), 1st to 3rd grade students in 
Somerville reduced their body mass index, and gained less weight than children in 
comparable communities.305,306 Similar benefits have been observed in the following 
decade for students at other grade levels in Somerville.305,306 
The policy and programmatic interventions similar to those presented here should 
be taken in concert in order to address a community’s unique area-level economic and 
social climate. Building upon the area-level advantages of a community may allow 
communities to better address the disadvantages they are faced with. By involving an 
array of stakeholders, such as businesses, governments, schools, and citizen groups, the 
community will be better reflected as these interventions are designed and implemented. 
Policymakers and funders should recognize the importance of these multi-faceted 




Future Research on Double Jeopardy  
The concept of double jeopardy suggests that the same exposure can have more 
adverse consequences among individuals with high allostatic load than among others.  
For example, among a nationally representative sample of US adults, the association 
between blood lead levels and BP was stronger among individuals with high allostatic 
load than among individuals with low allostatic load.170 Similarly, among a group of 
industrial workers, smoking interacted with allostatic load, resulting in greater risk for 
cardiovascular disease.307  
While the physiology of double jeopardy is not well understood, dysfunction 
across multiple physiologic systems may indicate compromised immune function.  For 
example, this compromised immune function may be expressed in an inability to contain 
inflammation, a key factor in development of disease.308–310 If a compromised immune 
system is faced with an external insult, there may be an excessive release of pro-
inflammatory cytokines, leading to excessive inflammation and damage to healthy cells, 
which in turn can lead to insulin resistance and endothelial dysfunction, both of which are 
signs if high cardiometabolic risk.308,310 
The concept of cardiometabolic risk, as assessed here, is similar to the concept of 
allostatic load. In the current study, exposure to chronic stress (i.e. area-level poverty) is 
associated with increased cardiometabolic risk, and allostatic load is also considered a 
consequence of exposure to chronic stress.203–206 Additionally, both concepts are 
considered to reflect functioning across similar physiologic systems (i.e. metabolic, 
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cardiovascular, adipose tissue), and both are concerned with preclinical levels of 
physiologic functioning.203–206   
Based on these similarities, the concept of double jeopardy in the allostatic load 
literature may be applicable to individuals with high cardiometabolic risk. As individuals 
with high cardiometabolic risk are considered to have poor functioning across multiple 
physiologic systems, their immune systems may not be capable of properly responding to 
additional external insults. Thus, compared to individuals with low cardiometabolic risk, 
individuals with high cardiometabolic risk may also have worse outcomes when exposed 
to hazards. This is in line with evidence suggesting adults with diagnosed diabetes, when 
compared to healthy individuals, have a higher risk of poor cardiovascular outcomes 
when exposed to ambient air pollution.311 
Further research is warranted to better understand cardiometabolic risk during 
adolescence, the potentially increased susceptibility to additional exposures, and how 
these factors influence health and racial/ethnic health disparities across the life course. 
Specifically, prospective longitudinal research is needed to better understand the 
relationship between cardiometabolic risk in adolescence and various chronic diseases in 
adulthood. These studies may provide evidence to support efforts to reduce 
cardiometabolic risk in adolescence, as this may be protective against increased 
susceptibility to external insults (such as air pollution and tobacco smoke) and the 
resulting increased risk for disease.  
Research should take advantage of natural experiments (e.g. tenant-based rental 
assistance programs, neighborhood revitalization initiatives) to better understand how 
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addressing various social determinants of health can reduce the risk for multiple poor 
health outcomes, especially among adolescents. Reducing cardiometabolic risk in 
adolescence may result in lower prevalence of cardiometabolic diseases such as diabetes 
and cardiovascular disease later in life. In turn, the concept of double jeopardy suggests 
that reducing cardiometabolic risk in adolescence could facilitate better physiological 
resilience to external insults such as the exposure to ambient air pollution or second-hand 
smoke, potentially mitigating the negative consequences of these exposures. More 
research is needed to better understand how programs aiming to improve area-level 
economic and social conditions can maximize their return on investment, reducing the 
prevalence of various chronic diseases and negative health outcomes throughout the life 
course. 
In conclusion, we observed that residence in the highest area-level poverty 
quartiles was associated with increased cardiometabolic risk among U.S. adolescents, 
independent of individual-level and area-level covariates. Additionally, we found 
evidence that these associations differ by race/ethnicity. Specifically, findings suggest a 
stronger association between area-level poverty and cardiometabolic risk among non-
Hispanic whites and Mexican Americans then among non-Hispanic blacks. Efforts taken 
to improve cardiometabolic health at the population-level and reduce racial/ethnic 
disparities in cardiometabolic diseases should include targeted area-level interventions 
that consider the strengths and weaknesses of the targeted areas, in order to improve the 








Appendix A. Tables 
Table 1. Weighted mean cardiometabolic index scores and biomarkers by independent variables (NHANES 1999-2012) 
Variable 
(Unweighted N; %) 
CMI 





Total (10415; 100) -.810 (-.884, -.737) 109.62 (109.34, 109.90) 60.72 (60.41, 61.04) 
Area-level Poverty    
Quartile 1(2599; 24.95)  -1.048 (-1.182, -.915) 109.06 (108.55, 109.58) 60.68 (60.10, 61.26) 
Quartile 2(2615; 25.10)  -.855 (-.984, -.726) 109.57 (109.04, 110.10) 60.70 (60.11, 61.29) 
Quartile 3(2584; 24.81) -.531 (-.694, -.367) 109.98 (109.39, 110.58) 60.86 (60.16, 61.55) 
Quartile 4(2595; 24.91)  -.535 (-.669, -.371) 110.56 (110.00, 111.12) 60.69 (60.04, 61.33) 
Racial Concentration    
Quartile 1(2599; 24.95)  -.792 (-.921, -.662) 109.14 (108.59, 109.68) 61.30 (60.71, 61.88) 
Quartile 2(2604; 25.00)  -.837 (-.992, -.682) 109.59 (109.04, 110.15) 60.88 (60.23, 61.53) 
Quartile 3(2605; 25.01) -.869 (-1.011, -.726) 109.65 (109.13, 110.16) 60.06 (59.50, 60.62) 
Quartile 4(2599; 24.95)  -.700 (-.845, -.556) 110.73 (110.22, 111.24) 60.22 (59.93, 60.91) 
Family PIR    
< 1 (3074 ; 29.52) -.590 (-.734, -.445) 109.99 (109.49, 110.49) 60.72 (60.12, 61.32) 
1-2.9 (4005; 38.45)  -.685 (-.809, -.561) 109.71 (109.27, 110.15) 60.53 (60.02, 61.05) 
3-4.9 (1606; 15.42) -.929 (-1.091, -.767) 109.61 (108.95, 110.26) 60.85 (60.15, 61.56) 
≥ 5  (967; 9.28) -1.225 (-1.422, -1.028) 108.92 (108.07, 109.78) 61.12 (60.21, 62.03) 
Missing (763; 7.33)  -.834 (-1.127, -.541) 109.65 (108.52, 110.77) 60.39 (58.90, 61.88) 
Age     
12-14 (3981; 38.22) -.810 (-.930, -.690) 106.86 (106.45, 107.28) 51.98 (57.44, 58.52) 
15-17 (3964; 38.06) -.759 (-.874, -.645) 110.49 (110.06, 110.93) 61.65 (61.17, 62.12) 
18-19 (2470; 23.72) -.896 (-1.054, -.738) 112.60 (111.99, 113.21) 63.60 (62.97, 64.22) 
Gender    
Female (5015; 48.15)  -.659 (-.763, -.034) 106.83 (106.48, 107.18) 61.74 (61.32, 62.16) 
Male (5400; 51.85)  -.952 (-1.055, -.849) 112.23 (111.82, 112.64) 59.78 (59.31, 60.24) 
Race/Ethnicity    
White (2756; 26.46)  -.855 (-.963, -.747) 109.42 (109.01, 109.83) 61.27 (60.80, 61.74) 
Black (3052; 29.30)  -.643 (-.759, -.526) 111.83 (111.40, 112.25) 60.71 (60.21, 61.21) 
Mex.Am. (3342; 32.09)  -.692 (-.817, -.567) 109.34 (108.90, 109.79) 58.33 (57.79, 58.87) 
CMI: Cardiometabolic risk index is a sum of z-scores for glycosylated hemoglobin levels, waist circumference, HDL cholesterol and total cholesterol, 
and for systolic and diastolic blood pressure. All z-scores were age and gender specific. Blood pressure z-score based on age, gender, and height. SBP: 
Systolic Blood Pressure (mmHg); DBP: Diastolic Blood Pressure (mmHg); HbA1c: Glycosylated Hemoglobin (% blood glucose); WC: waist 
circumference (cm); TC: total cholesterol (mg/dL); HDL-C: High Density Lipoprotein Cholesterol (mg/dL). Due to small cell size, missing values not 







Table 1 (cont.). Table 1. Weighted mean cardiometabolic index scores and biomarkers by independent variables (NHANES 1999-
2012) 
Variable 




Mean 95% CI 
TC 
Mean 95% CI 
HDL-C 
Mean 95% CI 
Total (10415; 100) 5.15 (5.15, 5.16) 81.42 (81.04, 81.81) 159.83 (159.00, 160.65) 50.69 (50.37, 51.01) 
Area-level Poverty     
Quartile 1(2599; 24.95)  5.13 (5.11, 5.14) 79.97 (79.31, 80.62) 160.14 (158.61, 161.66) 50.81 (50.21, 51.41) 
Quartile 2(2615; 25.10)  5.14 (5.13, 5.16) 81.57 (80.85, 82.29) 159.76 (158.19, 161.33) 50.38 (49.78, 50.98) 
Quartile 3(2584; 24.81) 5.18 (5.16, 5.19) 82.72 (81.82, 83.61) 159.63 (157.85, 161.40) 50.62 (49.94, 51.29) 
Quartile 4(2595; 24.91)  5.20 (5.19, 5.22) 82.83 (82.00, 83.66) 159.40 (157.87, 160.94) 51.05 (50.38, 51.72) 
Racial Concentration     
Quartile 1(2599; 24.95)  5.14 (5.12, 5.15) 81.54 (80.86, 82.23) 159.91 (158.38, 161.44) 50.08 (49.49, 50.66) 
Quartile 2(2604; 25.00)  5.14 (5.12, 5.15) 81.54 (80.74, 82.34) 159.34 (157.65, 161.03) 50.48 (49.84, 51.12) 
Quartile 3(2605; 25.01) 5.16 (5.14, 5.17) 81.44 (80.71, 82.17) 159.92 (158.36, 161.48) 50.93 (50.28, 51.59) 
Quartile 4(2599; 24.95)  5.21 (5.20, 5.23) 80.89 (80.11, 81.67) 160.36 (158.80, 161.93) 52.02 (51.38, 52.66) 
Family PIR     
< 1 (3074 ; 29.52) 5.18 (5.16, 5.19) 82.84 (82.08, 83.16) 159.58 (158.03, 161.12) 50.37 (49.75, 50.99) 
1-2.9 (4005; 38.45)  5.15 (5.14, 5.17) 81.86 (81.22, 82.05) 160.26 (158.92, 161.60) 50.19 (49.68, 50.70) 
3-4.9 (1606; 15.42) 5.15 (5.13, 5.17) 80.54 (79.66, 81.41) 158.71 (156.77, 160.65) 50.54 (49.77, 51.30) 
≥ 5  (967; 9.28) 5.12 (5.10, 5.14) 79.62 (78.62, 80.63) 160.49 (158.08, 162.90) 52.12 (51.20, 53.04) 
Missing (763; 7.33)  5.18 (5.15, 5.21) 81.65 (80.18, 83.12) 160.41 (157.59, 163.24) 51.62 (50.42, 52.82) 
Age      
12-14 (3981; 38.22) 5.18 (5.17, 5.19) 77.65 (77.07, 78.24) 158.59 (157.33, 159.85) 51.70 (51.18, 52.22) 
15-17 (3964; 38.06) 5.15 (5.13, 5.16) 82.35 (81.75, 82.95) 158.03 (156.68, 159.38) 49.99 (49.48, 50.51) 
18-19 (2470; 23.72) 5.13 (5.11, 5.14) 85.94 (85.13, 86.75) 164.82 (163.03, 166.61) 50.21 (49.54, 50.89) 
Gender     
Female (5015; 48.15)  5.14 (5.13, 5.15) 80.81 (80.28, 81.35) 162.54 (161.36, 163.72) 53.14 (52.67, 53.62) 
Male (5400; 51.85)  5.17 (5.16, 5.18) 81.99 (81.45, 82.54) 157.29 (156.15, 158.43) 48.39 (47.97, 48.82) 
Race/Ethnicity     
White (2756; 26.46)  5.12 (5.10, 5.13) 81.54 (80.97, 82.12) 160.17 (158.93, 161.42) 49.82 (49.34, 50.30) 
Black (3052; 29.30)  5.26 (5.25, 5.28) 80.66 (80.03, 81.29) 160.26 (159.09, 161.42) 54.25 (53.75, 54.75) 
Mex.Am. (3342; 32.09)  5.17 (5.16, 5.19) 83.44 (82.83, 84.06) 158.78 (157.60, 159.96) 50.36 (49.83, 50.89) 
CMI: Cardiometabolic risk index is a sum of z-scores for glycosylated hemoglobin levels, waist circumference, HDL cholesterol and total cholesterol, 
and for systolic and diastolic blood pressure. All z-scores were age and gender specific. Blood pressure z-score based on age, gender, and height. SBP: 
Systolic Blood Pressure (mmHg); DBP: Diastolic Blood Pressure (mmHg); HbA1c: Glycosylated Hemoglobin (% blood glucose); WC: waist 
circumference (cm); TC: total cholesterol (mg/dL); HDL-C: High Density Lipoprotein Cholesterol (mg/dL). Due to small cell size, missing values not 




Table 2. HLM models estimating the association between area-level poverty and 
cardiometabolic risk index 
 Overall Sample 
(n= 10415) 
Estimate (95% CI) 
White NH 
(n=  2756) 
Estimate (95% CI) 
Black NH 
(n=  3052) 
Estimate (95% CI) 
Mexican American 
(n = 3342) 





    
Quartile 1 Ref. Ref. Ref. Ref. 
Quartile 2 .266 (.069, .463) .260 (-.032, .552) -.121 (-.057, .335) .445 (.004, .885) 
Quartile 3 .522 (.322, .722) .807 (.452, 1.162) -.086 (-.513, .339) .679 (.257, 1.100) 
Quartile 4 .552 (.354, .751) .735 (.265, 1.204) .238 (-.163, .639) .508 (.086, .930) 
     
Variance in 
intercept (τ00) 
1.52* 1.84* 1.64* 1.50* 
Variance within 
tracts (σ2) 
4.41* 5.44* 3.88* 3.39* 
Model Fit: -
2LL 







    
Quartile 1 Ref. Ref. Ref. Ref. 
Quartile 2 .214 (.008, .420) .142 (-.161, .446) -.083 (-.548, .422) .445 (-.004, .894) 
Quartile 3 .427 (.203, .651) .591 (.203, .978) -.025 (-.473, .422) .678 (.234, 1.122) 
Quartile 4 .430 (.191, .670) .462 (-.046, .972) .325 (-.119, .771) .508 (.048, .969) 
     
Variance in 
intercept (τ00) 
1.53* 1.82* 1.64* 1.51* 
Variance within 
tracts (σ2) 
4.40* 5.43* 3.88* 3.38* 
Model Fit: -
2LL 





    
Quartile 1 Ref. Ref. Ref. Ref. 
Quartile 2 .218 (.012, .424) .155 (-.149, .460) -.071 (-.538, .394) .440 (-.009, .890) 
Quartile 3 .438 (.213, .665) .634 (.240, 1.028) -.001 (-.456, .453) .663 (.217, 1.109) 
Quartile 4 .451 (.204, .698) .541 (.014, 1.067) .369 (-.098, .836) .487 (.023, .952) 
Racial 
Concentration 
-.001 (-.004, .002) -.005 (-.016, .004) -.001 (-.005, .003) .003 (-.005, .012) 
     
Variance in 
intercept (τ00) 
1.53* 1.81* 1.64* 1.51* 
Variance within 
tracts (σ2) 
4.40* 5.43* 3.88* 3.38* 
Model Fit: -
2LL 
52509.17 13282.5 15551.1 17001.4 
 
CMI: Cardiometabolic Risk Index. Models predicting Cardiometabolic Index did not include Age, Gender, 
or BMI.  †Model includes NHANES Survey Cycle. ††Model includes Race/Ethnicity (except race-specific 
models), Family Income to Poverty ratio, and NHANES survey cycle. †††Model includes all variables in 






Table 3. HLM Models estimating cotinine as a mediator 
Variable Overall Sample 
(n= 10415) 
Estimate 95% CI 
White NH 
(n=  2756) 
Estimate 95% CI 
Black NH 
(n=  3052) 
Estimate 95% CI 
Mexican American 
(n = 3342) 
Estimate 95% CI 
CardioMet Index as 
outcome† 
Area-Level Poverty 
    
Quartile 1 Ref. Ref. Ref. Ref. 
Quartile 2 .222 (.020, .424) .260 (-.032, .552) -.121 (-.057, .335) .445 (.004, .885) 
Quartile 3 .444 (.228, .660) .807 (.452, 1.162) -.086 (-.513, .339) .679 (.257, 1.100) 
Quartile 4 .458 (.228, .689) .735 (.265, 1.204) .238 (-.163, .639) .508 (.086, .930) 
     
Cotinine as outcome 
model † 
Area-Level Poverty 
    
Quartile 1 Ref. Ref. Ref. Ref. 
Quartile 2 6.47 (2.33, 10.60) 8.25 (.57, 15.93) 1.98 (-6.496, 10.460) -1.47 (-6.06, 3.11) 
Quartile 3 6.41 (1.95, 10.86) 6.76 (-3.20, 16.73) 8.97 (.786, 17.169) -2.43 (-6.90, 2.03) 
Quartile 4 6.24 (1.49, 10.99) 20.75 (7.52, 33.98) 11.22 (2.847, 19.607) -2.15 (-6.69, 2.37) 
     
Cotinine predicting 
CardioMet Index†† 
    
Cotinine -.002 (-.003, .001) -.002 (-.003, .0008) -.003 (-.005, .001) -.002 (-.006, .0009) 




    
Cotinine -.002 (-.003, .001) -.002 (-.003, .0008) -.003 (-.005, .001) -.002 (-.006, .0009) 
Area-Level Poverty     
Quartile 1 Ref. Ref. Ref. Ref. 
Quartile 2 .222 (.016, .429) .159 (-.154, .457) -.067 (-.533, .399) .440 (-.009, .890) 
Quartile 3 .446 (.219, .673) .632 (.237, 1.027) .010 (-.445, .465) .662 (.215, 1.108) 
Quartile 4 .458 (.211, .706) .552 (.023, 1.080) .388 (-.080, .857) .487 (.023, .952) 
 
CarMet Index: Cardiometabolic Risk Index. Models predicting Cardiometabolic Index did not include Age, 
Gender, or BMI.  
 † Model includes area-level racial concentration, Race/Ethnicity, Family Income to Poverty ratio, and 
NHANES survey cycle. 
†† Model includes Race/Ethnicity, Family Income to Poverty ratio, and NHANES survey cycle at Level 1. No 
area-level poverty or racial concentration at level 2. 












Table 4. HLM Models estimating physical activity as a mediator 
Variable Overall Sample 
(n= 10415) 
Estimate 95% CI 
White NH 
(n=  2756) 
Estimate 95% CI 
Black NH 
(n=  3052) 
Estimate 95% CI 
Mexican American 
(n = 3342) 





    
Quartile 1 Ref. Ref. Ref. Ref. 
Quartile 2 .222 (.020, .424) .260 (-.032, .552) -.121 (-.057, .335) .445 (.004, .885) 
Quartile 3 .444 (.228, .660) .807 (.452, 1.162) -.086 (-.513, .339) .679 (.257, 1.100) 
Quartile 4 .458 (.228, .689) .735 (.265, 1.204) .238 (-.163, .639) .508 (.086, .930) 
     
PhysAct as 
outcome model †† 
Area-Level 
Poverty 
    
Quartile 1 Ref. Ref. Ref. Ref. 
Quartile 2 -.138 (-.289, .011) .094 (-.164, .354) .283 (-.080, .647) -.005 (-.398, .387) 
Quartile 3 -.178 (-.344, -.013) .205 (-.128, .538) .103 (-.245, .451) .115 (-.266, .497) 
Quartile 4 -.269 (-.447, -.090) .274 (-.165, .715) .433 (.079, .788) .101 (-.287, .491) 




    
PhysAct .089 (-.021, .200) .231 (.023, .439) .079 (-.132, .291) -.111 (-.311, .088) 




    
PhysAct .082 (-.028, .193) .204 (-.003, .411) .063 (-.149, .275) -.118 (-.318, .081) 
Area-Level 
Poverty 
    
Quartile 1 Ref. Ref. Ref. Ref. 
Quartile 2 .227 (.020, .433) .147 (-.157, .452) -.052 (-.524, .419) .518 (.065, .972) 
Quartile 3 .442 (.215, .670) .637 (.242, 1.032) -.014 (-.472, .444) .733 (.283, 1.18) 
Quartile 4 .478 (.231, .752) .578 (.052, 1.103) .391 (-.005, .003) .606 (.142, 1.070) 
 
CarMet Index: Cardiometabolic Risk Index. Models predicting Cardiometabolic  Index did not include Age, 
Gender, or BMI.  
 
 † Model includes area-level racial concentration, Race/Ethnicity, Family Income to Poverty ratio, and 
NHANES survey cycle. 
†† Logistic regression Model includes area-level racial concentration, Race/Ethnicity, Family Income to 
Poverty ratio, and NHANES survey cycle. 
††† Model includes Race/Ethnicity, Family Income to Poverty ratio, and NHANES survey cycle at Level 1. 









Table 5. Mean Family Income-Poverty Ratio by area-level poverty quartile and 
race/ethnicity 
 Area-level Poverty 










Overall (n= 10415) 3.34 (.03) 2.59 (.02) 1.95 (.02) 1.42 (.02) <.001 
White (n= 2756)  3.53 (.04)b,c 2.79 (.04) b,c 2.20 (.07) b,c 1.60 (.10) b,c <.001 
Black (n= 3052)  2.61 (.07)a 2.29 (.06)a,c 1.84 (.04) a,c 1.34 (.03)a <.001 
Mex.Am. (n= 3342)  2.55 (.07)a  1.91 (.04)a,b 1.54 (.03) a,b 1.33 (.03)a <.001 
Trend assessed with multiple means comparisons. 
a. Significant difference from White (p<.05) 
b. Significant difference from Black (p <.05) 

























Table 6. Comparison of scaled and mobile exam center weights: Full model 
 
 Method A Scaled Weights   Method B Scaled Weights   Mobile Exam Center 
Weights 
 Estimate (se) 95% CI  Estimate (se) 95% CI  Estimate (se) 95% CI 
Intercept -0.831 (0.161) -1.14, -.515   -0.857 (.165) -1.181, -.533  -.873 (.165) -1.198, -.548  
Area-level Poverty       
Quartile 1 Ref. - Ref. - Ref. - 
Quartile 2 .218 (0.105) .012, .424 .229 (.107) .019, .438 .218 (.105) .012, .425 
Quartile 3 .438 (0.115) .213, .665 .454 (.117) .223, .684 .443 (.120) .206, .680 
Quartile 4 .451 (0.126) .204, .698 .466 (.128) .215, .718 .459 (.136) .191, .727 
Percent Black NH -.001(0.001) -.004, .002 -.0007 (.001) -.004, .002 -.002 (.001) -.006, .001 















Appendix B. Figures 






























































































































































Appendix C. SAS Code 
Appendix C.1. 14 Year Weight Sample SAS Code 
if sddsrvyr=1 or sddsrvyr=2 then  
     MEC14YR  = 2/7 * WTMEC4YR ; /* for 1999-2002 */ 
if sddsrvyr=3 or sddsrvyr=4 or sddsrvyr=5 or sddsrvyr=6 or sddsrvyr=7 then 
























Appendix C.2. Scaling Weights to Census Tracts Sample SAS Code 
proc sort data = dataset; 
by tract;  
   run; 
proc summary data = dataset; 
   by tract; 
   var MEC14YR; 
   output out = intermediate 
      uss = sumsqw 
      sum = sumw 
      n = nj; 
   run; 
data dataset; 
   merge dataset intermediate; 
      by tract; 
   aw = MEC14YR/(sumw/nj); 
   label aw = "Method A"; 
   bw = MEC14YR/(sumsqw/sumw); 
   label bw = "Method B"; 
   run; 
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